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Abstract 
In Gram-negative bacteria, intrinsic antibiotic resistance is provided by three 
component efflux transporters. In Escherichia coli, MacAB-TolC is the first 
experimentally described ATP-driven tripartite efflux pump responsible for macrolide 
resistance and enterotoxin secretion (Kobayashi, Nishino et al. 2001; Yamanaka, 
Kobayashi et al. 2008). In this complex, MacB is the inner membrane (IM) ABC-type 
(ATP-Binding Cassette) transporter which utilizes the energy from ATP hydrolysis for the 
transport of substrates. MacB functions together with a periplasmic membrane fusion 
protein (MFP) MacA. MacA stimulates the ATPase activity of MacB by inducing the 
closure of the nucleotide binding domains (NBD) of MacB (Modali and Zgurskaya 2011). 
TolC, as a versatile outer membrane (OM) channel, forms complex with MacAB to 
facilitate the extrusion of substrates into the exterior environment. Up to now it is still 
unclear how MacAB and TolC associate with each other contributing to the export of 
substrates, as well as how the presence of ATP and substrates affects the functions of this 
complex. 
The first part of this dissertation focuses on understanding the mechanism of 
complex assembly of MacAB-TolC and the role of ATP in this process. We developed a 
real-time assay for the analysis of concurrent ATP hydrolysis and assembly of 
MacAB-TolC using surface plasmon resonance (SPR) technique. We found that MacB 
binds nucleotides with fast on- and off- rates and a low millimolar affinity. MacA-MacB 
forms a stable complex with nanomolar affinity and the binding of ATP increases the 
affinity of MacA-MacB interactions. These results strongly suggest that the binding of 
ATP brings MacB into a conformation with higher affinity towards MacA. Furthermore, 
 xiv 
 
the MacA-MacB complex remains unchanged during ATP hydrolysis cycle. We also 
found that the large periplasmic loop (LPL) of MacB is required for the MacA-dependent 
stimulation of MacB ATPse and the recruitment of TolC into the complex by MacA. 
Based on these findings, we propose a mechanism of complex assembly of MacAB-TolC 
complex. MacA has a higher affinity towards the ATP-bound state of MacB and promotes 
the closed conformation of MacB NBD for ATP hydrolysis. The MacA-dependent 
stimulation of MacB ATPase is coupled to the recruitment of TolC by MacA through the 
interactions between MacA and MacB LPL. 
The second part of this dissertation focuses on developing a new method for the 
study of membrane protein complex MacAB-TolC. For this purpose we reconstituted 
MacAB-TolC into lipid nanodiscs. We found that MacB containing nanodiscs can bind 
and hydrolyze ATP, suggesting that MacB is functional in nanodiscs. Interestingly, 
MacB
C56A/D643C
, which only exhibits 60% MacB ATPase compared to that of MacB
WT
 in 
detergent, shows ATPase activity similar to MacB
WT
 in nanodiscs. We conclude that 
reconstitution of MacB into lipid nanodiscs provides a more native environmen to 
investigate the biological and physiological functions of MacB and the mechanism of 
assembly of MacAB-TolC complex.  
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I. Introduction 
Since the discovery of the first antibiotic drug penicillin in 1928, many antibiotics 
have been found and manufactured to treat infectious diseases (Nikaido 2009). The 
discovery and usage of antibiotics had once been considered to be one of the most 
profound contributions to human life. However, in the past decade, an increasing number 
of bacterial pathogens have become resistant to antibiotics. The emergence of drug 
resistant pathogens leads to a serious problem that some therapeutic agents cannot be 
used for the treatment of infections anymore (Piddock 2006). The drug resistance 
phenomenon has been identified in micro-organisms, and also in mammalian cells 
recently (Sharma, Sharma et al. 2005). In addition, it spreads through cell populations 
rapidly (Higgins 2007). Nevertheless, it is more surprising that an increasing number of 
bacterial species show simultaneous resistance towards many structurally and chemically 
unrelated drugs, which is called the multiple-drug resistance (MDR) (Li and Nikaido 
2009). This MDR phenomenon dramatically reduces the efficiency of antibiotics and 
restricts the clinical use of certain antibiotic families (Nikaido and Pages 2012). In order 
to maintain the drug efficiency and develop new antibiotic drugs, extensive studies have 
been done to explore the mechanisms of bacterial drug resistance. 
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Figure I.1 Mechanisms of antibiotic resistance in bacteria. Figure Adopted from 
http://www.scq.ubc.ca/attack-of-the-superbugs-antibiotic-resistance. 
 
The commonly accepted mechanisms of bacterial drug resistance include the 
alteration of target proteins, the inactivation of drugs, the decrease of membrane 
permeability and the expression of drug efflux pumps (Figure I.1) (Higgins 2007). 
Bacteria obtain these drug resistance abilities through acquired and intrinsic mechanisms 
(Alekshun and Levy 2007). The acquired mechanism is related to the introduction of 
mutations in antibiotic targeted genes, which is accomplished by exchanging resistant 
traits through the processes of transduction, conjugation and transformation between 
bacteria species (Levy and Marshall 2004). The intrinsic mechanism is the contribution 
of naturally occurring genes, such as genes encoding many multiple-drug resistance 
(MDR) efflux systems. The MDR efflux systems recognize and extrude a broad range of 
structurally and chemically unrelated compounds (Zgurskaya and Nikaido 2000) and are 
considered to be the primary reason for drug resistance in bacteria. 
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The following section will concentrate on the brief description of MDR efflux 
systems in bacteria and then focus specifically on the introduction of the structural and 
functional bases of E. coli macrolide efflux transport system MacAB-TolC. 
I.1 Multiple-drug resistance (MRD) efflux complexes in bacteria.  
Drug efflux complexes contain transport proteins which utilize the metabolic energy 
for the extrusion of multiform substrates from the cytosolic compartment of cells into the 
external environment. These proteins can be found not only in prokaryotic but also in 
eukaryotic organisms (Van Bambeke, Balzi et al. 2000) and they contribute significantly 
to the existing drug resistance phenomenon (Borges-Walmsley, McKeegan et al. 2003; 
Webber and Piddock 2003). Active drug efflux transporters can be specific to one 
substrate, and are often called single-drug or group-specific efflux transporters. In 
addition, efflux transporters can be versatile to multiple structurally and functionally 
dissimilar organic compounds, and are called multiple drug resistance (MDR) efflux 
transporters (Lubelski, Konings et al. 2007). The mammalian P-glycoprotein is an 
ATP-driven efflux pump and is the first described MDR transporter (Paulsen 2003). 
MDR efflux transporters are also widespread throughout the bacteria kingdom (Paulsen 
and Lewis 2001). 
MDR efflux transporters can be classified into different superfamilies based on the 
energy source they use, the number of transmembrane (TM) helices they possess, the 
substrates they transport and the number of accessary protein they need (Piddock 2006). 
In bacteria, MDR transporters are commonly classified into two major groups based on 
the energy mode utilized for the extrusion of drugs (Lubelski, Konings et al. 2007): 
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primary active transporters and secondary active transporters. The primary active 
transporters contain the ATP-binding cassette (ABC) superfamily and utilize the energy 
from ATP hydrolysis to couple the drug export process against the drug concentration 
gradient. The secondary active transporters are energized by the proton motive force and 
are composed of superfamilies of H
+
- and Na
+
- antiporters (Paulsen, Brown et al. 1996; 
Webber and Piddock 2003). The MDR secondary transporters can be further divided into 
four major families based on the amino acid sequence homologies and predicted 
secondary structures (Figure I.2) (Piddock 2006):  
 
Figure I.2 Multiple-drug resistance (MDR) efflux pumps in Gram-positive and 
Gram-negative bacteria. Figure adopted and modified from (Piddock 2006) 
 
(I) the Major Facilitator Superfamily (MFS) transporters, which form the largest 
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group of secondary active transporters (Pao, Paulsen et al. 1998) and are predicted to 
have 12 or 14 TM helices with a large cytoplasmic loop between helix 6/7 (Saier, Beatty 
et al. 1999), (II) the Multidrug and Toxic-compound Extrusion (MATE) transporters, 
which have comparable size to the MFS transporters and are predicted to have 12 TM 
helices (Jack, Yang et al. 2001), (III) the Small Multidrug Resistance (SMR) transporters, 
which are relatively small size transporters and are putatively folded into 4 TM helices 
(Paulsen, Brown et al. 1996) and (IV) the Resistance Nodulation Division (RND) 
transporters, which are much larger than MFS transporters and are predicted to possess 
12 TM helices with large periplasmic or extracytoplasmic domains between helices 1/2 
and helices 6/7 (Mao, Warren et al. 2002; Murakami, Nakashima et al. 2002). MDR 
efflux systems are widespread in both Gram-positive and Gram–negative bacteria. A 
single bacterial species can express MDR efflux pumps from more than one superfamily 
and/ or express more than one kind of efflux pumps from the same superfamily. 
In Gram-negative bacteria, the presence of outer membrane bilayer and the 
expression of MDR efflux systems contribute to the intrinsic drug resistance (Lubelski, 
Konings et al. 2007). To allow the direct expulsion of drugs into the exterior environment, 
the majority of MDR efflux systems use the tripartite protein complexes to translocate 
drugs across both the inner and outer membranes (Nikaido 1996). These transport 
systems commonly consist of an inner membrane transporter, a membrane fusion protein 
(MFP) and an outer membrane protein channel (Borges-Walmsley, McKeegan et al. 
2003). The inner membrane transporters belong to one of the three superfamilies of 
proteins: the RND, ABC and MFS. They utilize the energy generated by either ATP 
hydrolysis or proton motive force to translocate substrates. MFPs are anchored to the 
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inner membrane by a lipid moiety or a single α-helix and function as physical linkers 
between the inner membrane transporters and the outer membrane channels. MFPs can be 
found in the tripartite efflux systems involved in the exportation of small molecules, 
proteins, oligosaccharides and each transport system is tended to have its own adaptor 
MFP (Yoneyama, Ocaktan et al. 1998). The outer membrane channels are multifunctional 
proteins involved in the translocation of both small drug molecules and large polypeptide 
toxin and are interchangeable between different drug efflux systems. The assembly of 
three protein components facilitates the direct transport of substrates from the cytoplasm 
or cytoplasmic membrane into the extracellular environment (Zgurskaya and Nikaido 
2000). MDR efflux systems in E. coli have been used as prototypes for the genetic and 
biochemical studies (Li and Nikaido 2004; Li and Nikaido 2009). As a result, the 
contributions of MDR to intrinsic and acquired resistance of E. coli have been explored 
in detail (Lubelski, Konings et al. 2007). In E. coli, MacB, as an ABC exporter, functions 
together with MacA and TolC (Kobayashi, Nishino et al. 2001). The following sections 
will be focused on structural and functional studies of the MacAB-TolC efflux pumps. 
 
I.2 The role of MacAB-TolC complex in macrolide resistance and toxin secretion in 
E.coli.  
The ABC transporter family is the largest in all paralogous protein families (Higgins 
2001). In E. coli, five putative ABC-type transporters are identified in the genome. 
However, only one ABC exporter MacB has been found to be related to drug resistance in 
E. coli (Kobayashi, Nishino et al. 2001). MacB is the first ABC-type exporter 
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experimentally characterized in Gram-negative bacteria. 
 
Figure I.3 Schematic model of the molecular construction of the ABC-type 
macrolide-specific drug exporter MacA-MacB system complexed with TolC in E. 
coli. Figure Adopted from (Kobayashi, Nishino et al. 2001; Xu, Song et al. 2011). 
  
MacB confers resistance against erythromycin when overexpressed in a 
hypersensitive strain lacking the major MDR pump AcrAB-TolC (Kobayashi, Nishino et 
al. 2001). Erythromycin is classified as a macrolide antibiotic and functions as a protein 
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synthesis inhibitor (Tenson, Lovmar et al. 2003). MacB exhibits resistance against 
macrolides containing 14- and 15- membered lactones but no or weak resistance against 
16-membered ones. To achieve the resistance against macrolides, MacB needs the 
assistance of two accessory proteins, the MFP protein MacA and the multifunctional 
outer membrane channel TolC (Tikhonova, Devroy et al. 2007). MacAB and TolC form 
tripartite complexes and utilize the energy generated by ATP hydrolysis to expel 
macrolides from the cytoplasm to the extracellular environment (Figure I.3). Recent 
studies indicate that the MacAB-TolC efflux system is also involved in the recognition 
and translocation of heat-stable enterotoxin STII from the periplasm to the exterior 
(Yamanaka, Kobayashi et al. 2008).  
Even though MacAB is unique in E. coli, its homologs are widely identified in all 
bacteria with some of them implicated in secretion of toxins and siderophores (Dubern, 
Coppoolse et al. 2008; Zgurskaya, Yamada et al. 2009). In contrast, TolC is exclusive to 
Gram-negative bacteria and forms tripartite complexes with diverse inner membrane 
transporters. 
 
I.3 Structural characterization of MacAB-TolC.  
MacAB and TolC belong to different membrane protein families and they exhibit 
some distinctive structural features.  
I.3.1 MacB.  
MacB is a noncanonic ABC transporter with only one nucleotide binding domain 
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(NBD) (Kobayashi, Nishino et al. 2001). Unlike most of the half-type transporters whose 
NBD are located at the C-termini of proteins, the NBD of MacB is at the N-terminus. 
This structural arrangement of MacB is similar to that of the ABCG subfamily which is 
involved in the regulation of lipid trafficking mechanisms in eukaryotes or humans 
(Schmitz, Langmann et al. 2001). However MacB shows no sequence homology to any 
ABCG family proteins. The NBD of MacB incorporates three conserved motifs in 
ABC-type transporters: a Walker A motif, a Walker B motif and an ABC signature motif 
LSGGQ. These motifs are the characteristic features of ABC superfamily. In general, the 
Walker A motif binds the phosphate groups of the nucleotides; the Walker B motif 
provides a conserved glutamate residue that nucleophilically attacks ATP in the presence 
of water molecule; the ABC signature motif only contacts ATP in the ATP-bound state. 
Usually, two ATP molecules are sandwiched between the Walker A motif from one NBD 
and the LSGGQ motif from the other NBD. 
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Figure I.4 Membrane topology of MacB. Figure adopted from (Kobayashi, Nishino et 
al. 2003). The putative transmembrane (TM) segments are shown in yellow squares. The 
Walker A, Walker B and signature sequence of MacB NBD are shown as pink rectangles.   
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MacB comprises four transmembrane (TM) segments and a large periplasmic 
domain formed by a loop connecting TM1 and TM2 (Kobayashi, Nishino et al. 2003) 
(Figure I.4). MacB has the least number of TM segments in half-type ABC transporters. 
Most ABC-type transporters have at least six TM segments and function as dimers with a 
total of 12 TM segments (Holland and Blight 1999). So far, the full length structure of 
MacB has not been solved. Nevertheless, the crystal structure of the periplasmic core 
domain (PCD) of the Actinobacillus actinomycetemcomitans (Aa)MacB is available (Xu, 
Sim et al. 2009).  
 
 
Figure I.5 The overall structure of MacB PCD. A. The side and top views of PCD are 
depicted. B. Folding topology of Aa MacB PCD. C. Secondary structures of the 
periplasmic regions of MacB (Left) and AcrB (Right). D.The periplasmic tip regions of 
MacB and AcrB. Figure adopted from (Xu, Sim et al. 2009). 
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There are two perpendicularly positioned components in Aa MacB PCD, a flexible 
N- and C- terminal regions and a rigid mixed αβ domain (Figure I.5 A). These two 
components are connected by flexible linkers and no physical interactions were observed 
between them. The mixed αβ domain is composed of a nine stranded β-sheet and three 
α-helices (Figure I.5 B). This domain is divided into the upper and lower subdomains by 
a shallow crevice in the middle (Figure I.5 A). In the full length MacB, the PCD is 
connected to the TM segments with the N- and C- terminal regions linked to TM1 and 
TM2, respectively. Structural comparison between the PCD of MacB and the periplasmic 
domain of the RND transporter AcrB reveals some similarities (Figure I.5 C). AcrB 
forms a homotrimer with the periplasmic domain composed of a TolC-docking domain 
and a porter domain (Murakami, Nakashima et al. 2002). The structure of the lower 
subdomain of MacB PCD is similar to that of the AcrB porter domain and the upper 
subdomain of MacB PCD shares some structural similarity to the tip region of the AcrB 
TolC-docking domain (Figure I.5 C, D). All these structural features of MacB could 
contribute to the substrate binding or complex assembly. The other putative periplasmic 
region between TM3 and TM4 of MacB cannot form any secondary structure and is not 
able to interact with PCD.  
I.3.2 MacA.  
MacA is a membrane fusion protein (MFP) with a TM segment at the N terminus, 
which is composed of 40 amino acid residues and anchors MacA to the inner membrane 
(Tikhonova, Devroy et al. 2007). Ec MacA was crystallized as a hexamer with a 3.0 Å 
resolution (Yum, Xu et al. 2009). The crystal structure shows three domains of MacA: the 
β-barrel domain, the lipoyl domain and the α-hairpin domain (Figure I.6 A). The 
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membrane proximal domain of MacA is not solved in this structure. MacA shares high 
structural similarity to other MPFs, such as Ec AcrA and its homologue Pseudomonas 
aeruginosa Pa MexA (Akama, Matsuura et al. 2004; Higgins, Bokma et al. 2004; 
Mikolosko, Bobyk et al. 2006). AcrA and MacA share 40% sequence similarity, but 
belong to different MFP subfamilies (Zgurskaya, Yamada et al. 2009). The coiled-coil 
α-hairpin of Ec MacA has six heptad repeats per helix and the length of the funnel stem 
of MacA is 11 Å longer than that of AcrA (Figure I.6 B). A superposition of the Ec MacA 
protomer onto Ec AcrA using the lipoyl domain as reference reveals that the α-hairpin 
domain and β-barrel domain of MacA differ from those of AcrA by 20°.  
 
 
Figure I.6 The overall structure of MacA. A. The asymmetric unit of Ec MacA. B. 
Superposition of the Ec MacA protomer onto Ec AcrA using the lipoyl domain as 
reference. C. The hexameric structure of Ec MacA. D. The top and bottom views of the 
hexameric structure of Ec MacA. Figure adopted from (Yum, Xu et al. 2009). 
 
The crystal structure of Ec MacA exhibits a funnel-like structure with a central 
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channel along the crystallographic pseudo-6-fold axis generated by a side-by-side 
packing interaction of six protomers (Figure I.6 C). The juxtaposition of the α-hairpin 
domains forms a 70 Å long and 30 Å wide stem and the lipoyl and β-barrel domains form 
a conical mouth with a 83 Å outside diameter (Figure I.6 D). The stem part of MacA 
hexamer is suggested to connect to the tip region of TolC (Xu, Song et al. 2011). 
Furthermore, MacB is suggested to be associated with the conical mouth of MacA. 
 
I.3.3 TolC.  
TolC, a versatile outer membrane channel, forms a conduit for the translocation of 
substrates across the outer membrane into the exterior. The crystal structure of Ec TolC 
was solved with a 2.1 Å resolution in 2000. It shows a mono-barrel homotrimer form 
(Koronakis, Sharff et al. 2000). Each of the three monomers contains four antiparallel 
β-strands and four antiparallel α-helical strands (Figure I.7 B). The overall structure of 
TolC is a tapered hollow cylinder with a length of 140 Å. It comprises a 40 Å long outer 
membrane β-barrel domain (the channel domain) and a contiguous 100 Å long α-helical 
barrel (the tunnel domain) projecting across the periplasmic space. A third domain, known 
as the equatorial domain, contains both α-helices and β-strands and situates around the 
midsection of the tunnel domain (Figure I.7 A). The structure of TolC provides a large 
solvent-filled interior cavity with a volume of 43,000 Å
2
. 
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Figure I.7 The overall structure of TolC. A. The structure of a TolC trimer. B. The 
structure of a TolC protomer. C. The ribbon depictions close (up) and open (down) states 
of TolC tunnel entrance, viewed from the periplasm. The coiled-coils of one protomer are 
colored (H3/4 and H7/8; numbering taken from Koronakis, Sharff et al. 2000) and the 
constraining intramonomer (I and II) and intermonomer (III) links are shown. Figures 
adopted from (Andersen 2003; Koronakis, Eswaran et al. 2004). 
 
 
Unlike other outer membrane proteins which contain one β-barrel per monomer, the 
channel domain of TolC exists as a distinct structure with 12 right-twisted β-strands 
forming a single β-barrel (Pautsch and Schulz 1998). To maintain the curvature of the 
β-barrel, small or unbranched amino acid side chains are tended to lie periodically on the 
inside of the barrel and residues with bulkier branched side chains lie on the outside of the 
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barrel. The outer membrane β-barrel of TolC is constitutively open to the exterior and the 
highly flexible small extracellular loops at the top are sites of colicin and bacteriophage 
attachment (German and Misra 2001).  
The TolC α-helical barrel is contiguous with the β-barrel domain and extends 
extensively into the periplasm. 12 α-helices (H2, H3, H6 and H7 of each monomer) arrange 
antiparallel to form an almost uniform cylinder in the upper section (Figure I.7 B). The 
α-barrel structure finishes with the equatorial domain and continues with the long helices 
H3 and H7 pairing with helices H4 and H8, respectively. The 12 α-helices have a 
left-handed superhelical twist throughout the entire α-helical barrel, but tend to untwist at 
the distal end comparing with the conventional coiled coils. The long helix H3 is straight 
with H4 coiling around it. The H3 and H4 together form the inner pair of helices. The outer 
pair of helices (H7 and H8) forms a conventional antiparallel coiled-coil bending inward 
and is responsible for the tapering of the periplasmic end of TolC. The coiled coils are 
stabilized by an intermeshing of side chains, known as “knobs-into-holes” packing. The 
hydrogen bonds within and between the helices and the salt bridges formed at the interface 
of monomers may contribute to the assembly and the trimerization of TolC. The dense 
packing of the coiled-coils is proposed to keep the periplasmic opening of TolC in its 
closed conformation. The weakening of the intramonomer and intermonomer links relaxes 
the inner coiled-coils from their constrained position to form the open conformation 
(Koronakis, Sharff et al. 2000; Andersen, Koronakis et al. 2002) (Figure I.7 C) 
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I.4 Functional characterization of MacAB-TolC 
MacAB-TolC efflux transport system is involved in the extrusion of macrolide 
antibiotics and heat stable enterotoxin STII. Each components of this tripartite complex 
has its own function.  
I.4.1 MacB.  
MacB functions as a dimer and can export macrolides and heat-stable enterotoxin STII 
across the membrane bilayer (Kobayashi, Nishino et al. 2001; Yamanaka, Kobayashi et al. 
2008). MacB confers resistance against macrolide antibiotics composed of 14- and 
15-membered lactones but no or weak resistance against 16-membered ones. As other 
ABC-type proteins (Davidson, Dassa et al. 2008), two ATP molecules are likely bound at 
the interface of MacB NBDs. The binding of nucleotides or nucleotide analogues to 
MacB can cause the same closed nucleotide-bound conformation of MacB. MacA is not 
needed for the binding of nucleotides to MacB (Modali and Zgurskaya 2011).  
When solubilized in Triton X-100, purified MacB displays a basal ATPase activity 
with a KM for ATP in a low millimolar range. The MacB ATPase activity is unresponsive 
to the putative substrate oleandomycin and the presence of accessory proteins MacA, 
TolC or both does not substantially affect the ATP hydrolysis of MacB (Tikhonova, 
Devroy et al. 2007). MacB lost all its ATPase activity in n-Dodecyl β-D-maltoside (DDM) 
micelles. Moreover, MacB ATPase is inhibited upon incorporation into the phospholipid 
bilayer. Furthermore, the basal ATPase activity of MacB in Triton X-100 is also 
diminished by lipids in all tested detergent/lipid ratio. It is suggested the formation of 
lipid bilayer leads to conformational changes in MacB.  
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In ABC transporters, K47 and D169 are the conserved catalytic residues located in 
the walker A and walker B motifs, respectively. Introducing either K47L or D169N 
substitution into MacB abolishes the ATPase activity of MacB completely. In addition, 
these variants fail to provide macrolide resistance to the drug hypersensitive strain, 
suggesting that MacB adopts a transport mechanism similar to that of the typical ABC 
transporters (Tikhonova, Devroy et al. 2007). 
 
I.4.2 MacA.  
MacA is the MFP in MacAB-TolC tripartite complex and it functions more than a 
physical linker between MacB and TolC. MacA is a hexameric protein that forms a 
tunnel-like structure connecting the peripalsmic domains of MacB and TolC. This 
hexamerization of MacA is essential for the fully function of MacAB-TolC efflux pump 
in vivo (Xu, Sim et al. 2009; Yum, Xu et al. 2009). MacA can directly bind TolC with 
(Tikhonova, Dastidar et al. 2009). The tip regions of the α-barrel of TolC and MacA 
interact in a tip-tip intermeshing cogwheellike manner (Xu, Song et al. 2011). MacA 
interacts with MacB and the presence of MacA increases the binding capacity of MacB 
towards erythromycin (Lin, Bavro et al. 2009). 
The ATPase activity of MacB is significantly stimulated by MacA in 
proteoliposomes and this MacA-dependent stimulation of MacB ATPase only occurs 
when MacA and MacB are incorporated into the same phospholipid bilayer. Previous 
studies suggest that MacA and ATP act synergistically to induce the closed conformation 
of MacB NBDs (Modali and Zgurskaya 2011). The MacA stimulation of MacB ATPase 
is concentration dependent and the presence of putative substrate oleandomycin does not 
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further stimulate the ATPase activity of MacB. The ATPase activities of MacB
K47L
 and 
MacB
D169N
 are not restored by MacA and the MacA analogue AcrA fails to increase the 
ATP hydrolysis rate of MacB, suggesting that the MacA-dependent stimulation of MacB 
ATPase is specific to MacB (Tikhonova, Devroy et al. 2007). Even though the 
periplasmic domain of MacA is sufficient to bind MacB, the N-terminal TM segment of 
MacA is required not only for the MacB ATPase stimulation in vitro but also for the 
macrolide resistance in vivo. These results imply that the MacA-dependent stimulation of 
ATP hydrolysis by MacA is functionally linked to macrolide resistance in vivo.  
The MP domains of MFPs are shown to play significant role in tripartite complex 
assembly (Ge, Yamada et al. 2009; Tikhonova, Yamada et al. 2011). In the MP domain 
of MacA, the C-terminal 70 amino acid residues are the most conserved residues between 
MFPs (Zgurskaya, Yamada et al. 2009). The MP domain of MacA plays a critical role in 
the stimulation of MacB ATPase by promoting the closed ATP-bound state of MacB 
NBDs. While assembling into the tripartite complex, the conformational transitions of the 
MacA MP domain modulate the ATPase activity of MacB. The MP domain of MacA acts 
as a switch in coupling the energy consumption by MacB to the extrusion of substrates 
outside the cell (Modali and Zgurskaya 2011). In agreement with previous studies of 
MFPs (Touze, Eswaran et al. 2004), MacA lacking the C-terminal end cannot bind MacB. 
Moreover, the C-terminal deletion mutant of MacA fails to stimulate the MacB ATPase 
and cannot facilitate the transport of macrolides. These results suggest that the function of 
MacB requires the MacA-MacB interactions on both sides of the membrane and within 
the membrane. Furthermore, all these studies imply that the MacB function is tighly 
regulated by MacA. 
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I.4.3 TolC.  
TolC can form complexes with different transporters. It is involved in two distinct 
export systems, the type I protein secretion system and the multidrug efflux pumps that 
transport a wide range of substrates (Andersen 2003; Koronakis, Eswaran et al. 2004). To 
date, at least eight multidrug transporters belonging to different superfamilies have been 
reported to require TolC for the extrusion of drugs, which are AcrAB, AcrD, AcrF, MdtF 
and MdtB from the RND superfamily, EmrB and EmrY from the MFS superfamily and 
MacB from the ABC-type superfamily. TolC associates with AcrA-AcrB forming the 
dominant MDR efflux tripartite complex in Gram-negative bacteria, which contributes 
significantly to reducing the periplasmic antibiotic concentrations (Nikaido 2009).  
The periplasmic entrance of TolC is believed to be opened upon association with the 
inner membrane complex (Zgurskaya, Krishnamoorthy et al. 2011). In addition, the 
binding of TolC to MFPs induces conformational changes in the MP domain of MFP, 
which could be required for the activation of the inner membrane transporters and the 
assembly of the tripartite complexes (Modali and Zgurskaya 2011; Tikhonova, Yamada 
et al. 2011).  
The expression level of TolC has no restriction to the drug efflux capacity of bacteria 
(Zgurskaya, Krishnamoorthy et al. 2011). Inactivation of TolC elevates the susceptibility 
of enteric bacteria to a broad range of antimicrobial agents like antibiotics, detergents, 
dyes, organic solvents, and others (Sulavik, Houseweart et al. 2001). TolC is also an 
important component for the maintenance of the pathogenicity and virulence in 
Gram-negative bacteria. The loss of TolC or one of its homologues diminishes the 
bacterial survival and virulence (Koronakis, Sharff et al. 2000). Moreover, TolC may be 
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related to the expulsion of metabolites (Hantke, Winkler et al. 2011), the tolerance 
against acidity (Deininger, Horikawa et al. 2011) and the maintenance of membrane 
integrity (Dhamdhere and Zgurskaya 2010). So far, how TolC is involved in different 
transport systems and how different inner membrane transporters trigger the opening of 
TolC for the extrusion of substrates are still obscure. 
I.5 Specific aims and goals of this dissertation. 
In E. coli, MacAB-TolC tripartite efflux complex is involved in the extrusion of 
macrolides and enterotoxin STII. In addition, MacAB homologs are widely identified in 
all Bacteria kingdom. Understanding the transport mechanism of MacAB-TolC system 
will give us insights into the MDR phenomenon in bacteria and probably serve as a 
prototype for the study of MacAB homologs. The main goal of this study is to 
characterize the mechanism of complex assembly of MacAB-TolC. We want to 
investigate the protein-protein interactions between MacAB-TolC in the presence and 
absence of ATP using surface plasmon resonance (SPR) approach. To achieve this goal, 
first, we will characterize the mechanism of complex assembly of MacAB–TolC and the 
role of ATP in this process. Second, we will reconstitute MacAB-TolC complex into 
nanodiscs to understand the mechanism of complex assembly in this membrane-like 
environment.  
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II. Experimental Procedures 
II.1 Construction of plasmids.  
To construct pTYB-ApoA-I plasmid expressing apolipoprotein A-I (ApoA-I) protein 
containing N-terminal Intein-tag, the coding sequence of apoA-I gene was amplified by 
PCR using pNFXex plasmid (Ryan, Forte et al. 2003) as a template. The PCR product 
was then cloned into NotI and SpeI restriction sites of pTYB11 vector (New England 
Biolabs). The constructed pTYB-ApoA-I plasmid was transformed into BL 21(DE3) for 
protein expression.  
In previous studies (Tikhonova, Devroy et al. 2007), macAB gene was cloned into 
pUC18 (Sigma) and pBAD/MycHis-C vectors (Invitrogen) to construct pUCMacAB and 
pBAB
his
 plasmids, respectively. D169N and Y14C/C56A substitutions were then 
introduced into pUCMacAB and pBAB
His
 plasmids to construct pUCMacABD169N and 
pBABYC
His
 plasmids. In order to insert D169N and C56A/Y14C substitutions into 
pBAB
His
 and pUCMacAB plasmids, both pUCMacABD169N and pBABYC
His
 plasmids 
were treated with enzyme PsiI. PsiI cuts between amino acid position 322 in MacA and 
343 in MacB. This enzyme treatment generated two fragments, a 1000 bp fragment 
containing the desired mutations and a larger fragment containing the rest portions of 
pUCMacABD169N and pBABYC
His
 plasmids. The purified 1000 bp fragments from 
pUCMacABD169N
 
and pBABYC
His
 were then exchanged and ligated back with the 
corresponding larger fragments. The insertion of the correct gene sequence was 
confirmed by DNA sequencing (Oklahoma Medical Research Foundation Sequencing 
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Facility). 
 
II.2 Site-directed mutagenesis.  
D643C substitution was introduced into MacB using a QuickChange XL 
site-directed mutagenesis kit (Stratagene). The pBB
His
 plasmid (Tikhonova, Devroy et al. 
2007) was used as a template for PCR. The resulting construct as sequenced in Oklahoma 
Medical Research Foundation Sequencing Facility to confirm the introduction of the 
desired substitution.  
To construct MacB
LPL
 mutant lacking the large periplasmic loop (LPL), DNA 
sequences encoding the N-terminal 1-301 amino acid and C-terminal 518-648 amino acid 
fragments of MacB were amplified by PCR using pBB
His
 plasmid as a template. The two 
DNA fragments were then ligated by PCR and the DNA product was cloned into NcoI 
and PstI restriction sites of pBAD/MycHis-C. The same deletion of MacB was also 
introduced into pUCMacAB and pBAB
His
 plasmids. The DNA sequence of macA gene 
was amplified together with the DNA sequence encoding the N-terminal 1-301 amino 
acids of MacB by PCR using pUCMacAB plasmid as a template. The DNA sequence 
encoding the C-terminal 518-648 amino acids of MacB was also amplified by PCR using 
pUCMacAB plasmid as a template. The two DNA fragments were then ligated by PCR 
and the DNA product was cloned into NcoI and PstI restriction sites of pUCMacAB 
plasmids to construct pUCMacABLPL plasmid. The pBABLPL
His
 plasmid was 
constructed following the same protocol. 
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In order to introduce the Y14C/C56A substitutions into pBAB
His
 plasmid, the DNA 
sequence of macA gene plus the DNA sequence encoding the first 20 amino acids of 
MacB was amplified by PCR using pBAB
His
 plasmid as a template with an Y14C 
substitution introduced in macB gene. The DNA sequence encoding the 21-648 amino 
acids of MacB was amplified by PCR using pBBYC
His
 plasmid as a template. The two 
DNA fragments were then ligated by PCR to obtain full length macAB gene containing 
C56A/Y14C substitutions. The DNA product was cloned into NcoI and PstI restriction 
sites of pBAD/MycHis-C to construct pBABYC
His
 plasmid. 
 
II.3 Protein assays. 
II.3.1 SDS-PAGE and western blotting. 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis SDS-PAGE and 
immunoblotting were performed by standard methods (Tikhonova, Devroy et al. 2007). 
Samples pre-mixed with the sample buffer plus β-mercaptoethanol were boiled and 
separated by 12 % SDS-PAGE followed by Coomassie Brilliant Blue (CBB) staining or 
silver staining. For immunobloting analysis, proteins were transferred onto 
polyvinylidene difluoride (PVDF) membranes at 75 V for 1 hr. The membranes were kept 
in blocking buffer (5% dry milk) at 4 ºC overnight or at Room Temperature (RT) for 1 hr 
and then incubated with either one of anti-MacB, anti-MacA or anti-TolC rabbit 
polyclonal antibodies (Tikhonova and Zgurskaya 2004; Tikhonova, Devroy et al. 2007) 
followed by alkaline-phosphatase-conjugated anti-rabbit IgG antibody (Sigma). The 
proteins of interest were further visualized by substrates 5-bromo-4-chloro-3-indoyl 
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phosphate (BCIP) and nitro blue tetrazolium (NBT).  
To confirm the biotinylation of proteins, proteins were separated by 12% 
SDS-PAGE, transferred onto the PVDF membrane, incubated with streptavidin-alkaline 
-phosphatase (Sigma) and visualized by BCIP and NBT. 
 
II.3.2 Protein concentration determination.  
Protein concentrations were determined using Bradford Protein Assay (Bio-Rad) or 
DC Protein Assay (Bio-Rad) with bovine serum albumin (BSA) as a standard. To 
determine the concentrations of proteins reconstituted into proteoliposomes or lipid 
nanodiscs, the protein samples and increasing concentrations of BSA were boiled and 
separated by 12% SDS-PAGE. Gels were stained with CBB and scanned using CanoScan 
D1230U scanner. Protein intensities were analyzed by ImageQuant Program (Molecular 
Dynamics) or Image Processing and Analyzing in Java (Image J). The quantitative data 
of BSA intensities were then plotted as a function of BSA concentrations to generate a 
standard curve for the calculation of protein concentrations. The concentrations of 
proteins were then determined using this standard curve. 
 
II.4 Purification of ApoA-I. 
E. coli ER2566 cells bearing the pTYB-ApoA-I were cultured in 4 L Luria-Bertani 
(LB) broth medium (+ 100 µg/ mL ampicillin) at 37°C. When the culture OD600 reached 
about 0.7, the expression of Intein-apoA-I fusion protein was induced by the addition of 
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Isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.4 mM at 
12°C for 20 hrs. Cells were collected by low speed centrifugation and resuspended in 
buffer 20 mM Tris-HCl (pH, 8.5), 5 mM Ethylenediaminetetraacetic acid (EDTA), 1 mM 
phenylmethane-sulfonylfluoride (PMSF), 5 mM MgCl2 and 0.05 mg/mL 
Deoxyribonuclease I (DNAase I). French Press was used to disrupt cells and unbroken 
cells were removed by low speed centrifugation. The cell lysate was mixed with 3 times 
volume of 20 mM Tris-HCl (pH, 8.5), 500 mM NaCl, 1 mM PMSF (buffer A) 
supplemented with 2% Triton X-100 (TX-100) and the diluted cell lysate was mixed at 
4°C overnight to solubilize Intein-apoA-I. Next day, the cell lysate was centrifuged at 
86,399 g for 40 min at 4°C and the supernatant was applied onto a chitin column 
equilibrated with buffer A supplemented with 0.2% TX-100. The column was flushed 
with 10 bed volumes of buffer A supplemented with 0.2% TX-100 followed by 10 bed 
volumes of buffer A. Induction of the on column cleavage was conducted by quickly 
flushing the column with 3 bed volumes of buffer A supplemented with 50 mM 
Dichlorodiphenyltrichloroethane (DTT) and keeping the column at RT for 16 hrs. The 
column was washed with fresh cleavage buffer and ApoA-I protein was eluted from the 
column. The DTT induced column cleavage can be repeated 3-4 times until the majority 
of ApoA-I protiens were self-cleaved from the column. Purified ApoA-I was kept at 0°C 
in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl and 1 mM PMSF buffer for further usage. 
II.5 Purification of MacAB-TolC components. 
All proteins used in this study contained C-terminal 6-His-tags. MacA, MacB, TolC, 
MacA
S 
and their derivatives were purified as described before (Zgurskaya and Nikaido 
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1999; Tikhonova and Zgurskaya 2004).  
For MacA and MacB purification, E. coli cells carrying corresponding plasmids for 
expression were cultured in LB medium at 37°C and induced by 0.1% arabinose when 
OD600 reached 0.6. After three hours, cells were collected by low speed centrifugation 
and resuspended in buffer containing 20 mM Tris-HCl (pH, 8.0), 5 mM EDTA, 1 mM 
PMSF, 100 µg/mL lysozyme (Sigma). Sonication was used to lyse the cells and unbroken 
cells were removed by low speed centrifugation. Membrane fractions of MacA
WT 
and 
MacB variants were collected at 163,348 g and 194,398 g at 4°C for 1.5 hrs, respectively. 
The membrane fractions of MacB and MacA were then solubilized by incubating in 20 
mM Tris-HCl (pH 7.0), 200 mM NaCl, 1 mM PMSF, 0.1 mM β-mercaptoethanol, 5 mM 
imidazole buffer (MacB buffer) supplemented with 5% TX-100 and 20 mM Hepes-KCl 
(pH 7.7), 200 mM NaCl, 1 mM PMSF and 5 mM imidazole buffer (MacA buffer) 
supplemented with 5% TX-100 at 4°C overnight, respectively. The next day, insoluble 
proteins were separated at 86,399 g for 40 min at 4°C and the supernatant was loaded 
onto Cu
+2
-charged NTA column (Novagen) equilibrated with MacB or MacA buffer 
supplemented with 0.2% TX-100. The majority of proteins were eluted by MacA or 
MacB buffer supplemented with 100-500 mM imidazole. Imidazole was removed by 
dialysis.  
For TolC purification, E. coli cells carrying corresponding plasmids for expression 
were cultured in LB medium at 30°C and induced overnight by 0.4 mM IPTG when 
OD600 reached 0.3-0.5. French Press was used to lyse the cells and the membrane 
fractions were separated at 163,348 g for 1.5 hrs at 4°C. The isolated membrane pellet 
was resuspended and incubated in 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM 
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PMSF, 20 mM MgCl2 and 0.5% TX-100 buffer for 30 min to remove inner membrane 
and membrane associating proteins. The outer membrane fraction was separated at 
86,399 g for 2 hrs at 4°C and solubilized in 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 
mM PMSF buffer supplemented with 5% TX-100 at 4°C overnight. The purification 
procedure was the same as that of MacB. 
For MacA
S
 purification, cytoplasmic fraction of the cell lysate was separated at 
86,399 g for 40 min at 4°C and loaded directly onto Cu
+2
-charged NTA column 
(Novagen). MacA
S
 was purified as MacB but without the presence of TX-100. 
II.6 Co-purification of MacAB-TolC complex. 
The pBB
His
 plasmid expressing 6-His-tagged MacB
His
 and its derivatives or pBAB
His
 
plasmids expressing MacA
WT
 together with MacB
His
 variants were transformed into E.coi 
W4680AD (ΔacrAB, ΔacrD) strain. Cells were cultured in 200 mL LB medium 
supplemented with 100 µg/mL ampicillin at 30°C and induced for 3 hrs by adding 
L-arabinose to final concentration 0.1% when OD600 reached 0.7. Protein purification 
procedure was the same as that of MacB described above. The 100 mM imidazole 
fractions were used for further analysis. 
 
II.7 ATPase assay. 
To characterize the ATPase activity of MacB in detergent solution at different pH, 20 
mM HEPES-KOH (pH 7.0), 5 mM DTT, 50 mM KCl, 0.2% TX-100 buffer and 20 mM 
MES-KOH (pH 6.0), 100 mM NaCl, 0.2% TX-100 buffer were used as the reaction 
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buffers for the measurements of the ATP hydrolysis rate of MacB. 0.2-0.42 μM of 
purified MacB
His
 and its derivatives were added to the reaction mixture prepared with 
buffers of different pH. The ATP hydrolysis was measured at both 20°C and 37°C. The 
32
P γ-phosphate labelled ATP (3000 Ci mmol-1, Amersham) was pre-mixed with 
unlabelled Mg-ATP and then added at the concentrations indicated in the corresponding 
figures. At time points of 0, 4, 8, 12, 16 min, one microlitre aliquots were removed from 
the reaction and mixed with 10 μL of the stop buffer containing 50 mM Tris-HCl (pH 
8.0), 20 mM EDTA (pH 8.0), 0.5% SDS, 200 mM NaCl, 0.5 mg/mL proteinase K. The 
samples were incubated for at least 20 min at 55°C to stop the reaction and then one 
microlitre of sample was spotted on PEI-F cellulose. The separation of components in 
each reaction was carried out by thin-layer chromatography (TLC) running in 10% 
formic acid and 0.5 mM LiCl. The amounts of the free Pi were quantified using Storm 
PhosphoImager and ImageQuant Software (Molecular Dynamics). The ATP hydrolysis 
rates or specific ATPase activities of MacB variants were calculated. When indicated, 
MacA
WT 
was pre-mixed with MacB
 
variants for 15 min before adding into the reaction 
mixture.  
For kinetic measurements of MacA-dependent ATP hydrolysis, increasing 
concentrations of ATP were added into reactions. The rate of ATP hydrolysis was plotted 
as a function of ATP concentrations and the data were fit into Michaelis-Menten equation 
using Origin 8. The Michaelis-Menten equations are given below: 
 
 
max
M
V S
v
K S


   
 m a x c a t tV k E       
Here, Vmax represents the maximum rate achieved by the system, KM is the substrate 
concentration at which the reaction rate is half of Vmax, kcat measures the number of 
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substrate molecules turned over per enzyme molecule per second, kcat/KM, this ratio is 
often thought of as a measure of enzyme efficiency. 
II.8 Reconstitution of proteins into proteoliposomes and nanodiscs. 
II.8.1 Reconstitution of proteins into proteiliposomes. 
E. coli polar lipids (Avanti) were resuspended in the reconstitution buffer containing 
20 mM HEPES-KOH (pH 7.0), 5 mM DTT to the final concentration of 20 mg/mL. 
Lipids were destabilized with TX-100 in the final concentration of 0.45% and incubated 
at RT for 15 min. The reconstitution of proteins into liposomes was done by slowly 
adding a 25-50 µg protein sample into the destabilized liposome suspension, followed by 
incubation at RT for 30 min and slow removal of TX-100 with Biobeads SM-2 (Bio-Rad). 
After removing excess of beads with low speed centrifugation, proteoliposomes were 
diluted two times with reconstitution buffer (20 mM HEPES-KOH pH 7.0, 5 mM DTT) 
and collected by ultracentrifugation at 53,9994 g for 1 hr at 4°C. The pellet was 
resuspended in reaction buffer (20 mM HEPES-KOH pH 7.0, 5 mM DTT, 50 mM KCl) 
and then briefly sonicated. The resulting proteoliposomes were analyzed by quantitative 
SDS-PAGE to determine protein concentrations and used for assays within 2-3 days.  
The ATP hydrolysis activities of MacB and MacAB in proteoliposomes were 
analyzed as described in section II.6 with following modifications. The final 
concentration of MacB in reactions was kept at 0.3-0.7 μM. The corresponding 
concentration of MacA in MacAB proteoliposomes was around 0.75-3.85 μM with 
calculated MacB/MacA ratio between 1:2.5 and 1:5.5. All the reactions were carried out 
in the reaction buffer without TX-100. To load ATP into proteoliposomes, the samples 
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were quickly frozen in liquid N2 and sonicated after addition of ATP to reaction mixture. 
After three rounds of freezing and sonication, the samples were briefly pelleted down and 
immediately placed at 37°C. Reactions were carried out at 37°C and the amounts of the 
released Pi were analyzed by thin-layer chromatography as described in section II.6. 
II.8.2 Reconstitution of proteins into nanodiscs.  
E. coli polar lipids (Avanti) were resuspended in the reconstitution buffer containing 
20 mM Tris-HCl (pH 8.0), 0.5 mM EDTA, 5 mM DTT to the final concentration of 20 
mg/mL. Lipids was solubilized by addition of 10% TX-100 to the final concentration 3% 
and incubation  37°C for 1 hr. 60-120 µg of the purified MacB was slowly added into 
destabilized lipids and incubated at 37°C for 1 hr. ApoA-I was then added to the 
protein/lipids mixture and incubated at 37°C for 1 hr. The final concentration of each 
component was 80 μM ApoA-I, 5.6 mM lipids, 14 mM TX-100 and 8 μM MacB 
corresponding to the molar ratio 1:70:175:0.1. To remove TX-100, samples were 
extracted with Bio-Beads SM-2 (BioRad), resulting in the formation of MacB-containing 
nanodiscs (MacB nanodiscs). For reconstitution of empty nanodiscs, ApoA-I was added 
to lipid/TX-100 mixture immediately after the solubilizaiton step with the same molar 
ratio as above.  
After reconstitution of MacB nanodiscs, the MacB nanodiscs were further purified 
by loading onto Ni
2+
-charged NTA column equilibrated with the washing buffer 
containing 20 mM Tris-HCl (pH 8.0) and 100 mM NaCl. MacB nanodiscs were eluted by 
the washing buffer supplemented with 500 mM Imidazole. The eluted fractions were 
analyzed by 12% SDS-PAGE followed by silver staining. Fractions containing MacB 
nanodiscs were dialyzed against the reconstitution buffer to remove imidazole. The same 
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protocol was used to reconstitute TolC nanodiscs, but DDM was used as a detergent 
instead of TX-100. For the immobilization of empty nanodiscs, Cap-Biotin-PEG-PE 
(Avanti) was premixed with E. coli polar lipids in the molar ration 1:20 Cap-PE to E. coli 
and empty nanodiscs were reconstituted as described above. 
ATP hydrolysis of MacB in nanodiscs was measured as described in Section II.6 
except detergent TX-100 was omitted from the reaction buffer. MacA
S
 or TolC nanodiscs 
were pre-mixed with MacB nanodiscs and incubated for 15 min prior to addition into the 
reaction mixture. Reactions were carried out at 37°C and the amounts of released Pi were 
analyzed by thin-layer chromatography as described in Section II.6. 
 
II.9 Limited proteolysis. 
For proteolysis in vitro, 0.42 μg of purified MacB variants were pre-mixed with 
MES buffer (pH 6.0) (20 mM MES-KOH pH 6.0, 100 mM NaCl, 0.2% TX-100, 8 mM 
MgCl2) or HEPES buffer (pH 7.0) (20 mM HEPES-KOH pH 7.0, 100 mM NaCl, 0.2% 
TX-100, 8 mM MgCl2) supplemented with 4 mM nucleotide when indicated and 
incubated on ice for 5 min to allow the nucleotide binding. Proteolysis was carried out in 
the presence of increasing concentrations of trypsin (0.01, 0.1, 1.0, 10 μg/mL) in MES 
buffer (pH 6.0) or HEPES buffer (pH 7.0) at 37°C for 15 min. Reactions were terminated 
by boiling in the SDS-sample buffer for 5 min. MacB fragments were resolved on 12% 
SDS-PAGE and visualized by anti-MacB immunoblotting.  
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II.10 Minimum Inhibitory Concentration (MIC) measurements. 
MICs of oleandomycin and erythromycin were determined in 96 well plates as 
described previously (Tikhonova and Zgurskaya 2004). pUCMacAB plasmids were 
transformed into E. coli W4680AD (ΔacrAB, ΔacrD) cells. Approximately 105 
exponentially growing cells (OD600 0.4-0.6) were inoculated into LB medium 
supplemented with two-fold increasing concentrations of drugs. The cell growth was 
visualized after incubation at 30°C overnight. The MICs of the drugs were determined as 
the lowest concentration of drugs that completely inhibits cell growth. 
 
II.11 Surface Plasmon Resonance (SPR). 
BIAcore 3000 biosensor and SensiQ Pioneer systems were used to characterize 
binding reactions (Tikhonova, Dastidar et al. 2009; Tikhonova, Yamada et al. 2011).  
Biotinylation.  
Tris [2-carboxyethyl] phosphine hydrochloride (TCEP) disulfide reducing gel was 
used to reduce the disulfide bonds formed in MacB-Cys variants. 200 µL of 0.5-0.9 
mg/mL proteins were loaded onto an equal volume of the TCEP gel equilibrated with 
buffer containing 20 mM Tirs-HCl (pH 7.0), 150 mM NaCl, 5 mM EDTA, 0.2% TX-100 
and incubated at RT for 45 min. The proteins were then eluted from the column with the 
same buffer in the first two or three fractions. The protein concentrations were 
determined by Bradford assay using BSA as a standard. 20 mM Maleimide-Polyethylene 
 34 
 
glycol (PEG2)-Biotin (MP-biotin) in phosphate buffered saline (PBS) buffer was freshly 
prepared. Reduced proteins were mixed with biotin solution to a 20:1 MP-biotin to 
protein molar ratio and the mixtures were incubated on ice for 2 hrs. To remove excessive 
thio-reagent, the biotin-protein mixtures were loaded onto NAP-5 column (GE 
HealthCare, Sephadex G-25) equilibrated with elution buffer containing 20 mM Tirs-HCl 
(pH, 7.0), 150 mM NaCl, 5 mM EDTA, 0.2% TX-100. Proteins were eluted with the 
elution buffer and the 0.5 mL fractions were collected. To ensure the removal of free 
biotin from the biotinylated proteins, the biotinylated protein samples were dialyzed 
against the elution buffer. The biotinylation of MacB variants as further confirmed using 
12% SDS-PAGE followed by western blotting.  
Immobilization.  
Surface activation and protein immobilization procedures were performed as 
reported (Tikhonova et al., 2009, 2011). The Biacore system and a Streptavidin-coated 
SA biosensor chip (Biacore) were primed in the HEPES running buffer (pH 7.4) 
containing 20 mM HEPES-KOH, 150 mM NaCl, 0.2% TX-100. In order to clean up the 
surface, 50 mM NaOH and 1 M NaCl buffer were injected over the surfaces at a 40 
µL/min flow rate for 1 min three times followed by 500 mM MgCl2 at a 40 µL/min flow 
rate for 1 min. Approximately 0.01 µg/mL of biotinylated proteins were injected for 4 
min at a low rate of 10 μL/min into a flow cell. The injection was stopped when desired 
concentrations of proteins were immobilized onto the surfaces. A protein-free flow cell 
prewashed with NaOH/NaCl solution and MgCl2 was used as a control. TolC
A269C
 was 
immobilized onto a COOH2 chip using a previously described thiol-coupling protocol 
(Tikhonova, Dastidar et al. 2009). 
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Data collection and normalization.  
The analyte samples were prepared in the appropriate running buffer and filtered to 
remove protein aggregates. The concentrations of proteins were determined by Bradford 
or DC Protein Assay using BSA as a standard. All experiments were performed in MES 
running buffer (pH 6.0) containing 20 mM MES-KOH, 150 mM NaCl, 0.2% TX-100 or 
HEPES running buffer (pH 7.0) containing 20 mM HEPES-KOH, 150 mM NaCl, 0.2% 
TX-100. 8 mM MgCl2 was added into the running buffers when indicated. For kinetic 
study, 5-6 two fold serial dilutions of analytes (proteins, nucleotides and MgCl2) were 
prepared and injected over the surfaces at a 50 μL/min flow rate for 2 min. The samples 
were injected over MacB and control surfaces simultaneously. Nucleotides were 
pre-mixed with proteins before injections when indicated. The surfaces were regenerated 
between each analyte injection by injecting regeneration buffer containing 500 mM 
MgCl2, 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.2% TX-100 for 2 min. In order to 
wash out the remaining MgCl2, the running buffer was injected over the surfaces for 1 
min after each regeneration step. To acquire a response signal specific to the 
analyte-ligand interaction, the injection start time for the original sensorgrams was 
aligned and the signal on the control surface was subtracted from the total response on 
the ligand surface. To account for instrumental noise and discrepancy in buffer 
compositions, the running buffer was injected over the surfaces. Furthermore, the signal 
from the running buffer was also subtracted from the total response on the ligand surface 
as referred to the double referencing step. 
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Data analysis.  
To determine the kinetic parameters, the BIAevaluation (GE Healthsciences) 
software was used to fit data into several common bimolecular interaction models. Due to 
the fast association and dissociation rates, the binding curves of nucleotides to MacB 
could not be fit into any kinetic models. The normalized steady state binding responses of 
nucleotides were plotted as a function of nucleotide concentrations.  
The binding curves of MacA to MacB were fit globally into Two-State reaction (TS) 
model. Schematic representation and equations relevant to this model are given below: 
     
 
1 2
1 2
1 1 2
2 2
(1)
( )
(2)
( )
(3)
(4) t
k k
A B A B A B
k k
A B
k A B k A B k A B
t
A B
k A B k A B
t
R A B A B

 

 

 


       
 
      
 
         
       
The equilibrium dissociation constant for this model is: 
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where [A] is the concentration of analyte; [B] is the ligand binding capacity; [A·B] 
and [A·B*] are intermediate and final complexes, respectively; k-1, k-2, k1, and k2 are 
microscopic rate constants; and Rt is the total SPR response, which is directly 
proportional to [A·B] + [A·B*]. 
The observed rate constant is:  
 6 obs a dk k A k  （）   
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where ka is the rate constant for association, kd is the rate constant for dissociation 
and [A] is the analyte concentration determined by fitting sensorgrams locally into a 
simple bimolecular interaction model using BIAevaluation software. 
 
II.12 Size-exclusion chromatography (SEC). 
High-performance liquid chromatography (HPLC) was used to further purified 
homogeneous nanodiscs or MacB/TolC nanodiscs. The nanodiscs samples were loaded 
onto YMC-Pack Diol-300 size exclusion column with a flow rate of 1 mL/min. The 
presence of protein was detected by absorbance at 280 nm and fractions were collected 
every 0.5 min. The protein composition of each fraction was determined using 12% 
SDS-PAGE followed by silver staining. To determine the size of the nanodisc particles, 
samples were pre-mixed with a standard containing carbonic anhydrase (CA, 29 kD, 
RM=2.01 nm), bovine serum albumin (BSA, 66 kD, RM=3.61 nm), alcohol 
dehydrogenase (AD, 150 kD, RM=4.65 nm), thyroglobulin (Tg, 440 kD, RM=8.58 nm) 
and loaded onto the column. The MWs of standard proteins were plotted as a function of 
protein radii. The radii of nanodisc particles were calculated from the standard curve.  
To further confirm the homogeneity of nanodisc particles, the samples were reloaded 
onto the SEC column running at 0.1 mL/min and the presence of protein was detected by 
absorbance at 280 nm. 
To determine the oligomeric state of MacA and MacB, 5-10 μg of purified MacAS, 
MacA
WT
 and MacB were pre-mixed with a similar amount of a standard containing BSA 
(66 kD), alcohol dehydrogenase (150 kD) and ferritin (440 kD). The mixtures were 
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loaded onto self-packed 1 mL Sephacryl 
TM 
S-300 column equilibrated with MES (pH 6.0) 
running buffer with or without 8 mM MgCl2. Fractions were collected and analyzed on 
12% SDS-PAGE followed by silver staining. The intensity of protein bands on 
SDS-PAGE was further analyzed by Image J and plotted against fraction number. 
 
II.13 Lipid concentration determination. 
To analyze reconstituted nanodiscs, the lipid concentration was determined by 
measuring the inorganic phosphorus concentration as described in (Fiske and Subbarow 
1925; Chen, Toribara et al. 1956) . A standard containing 1, 3, 5, 7 and 9 mM KH2PO4 
was prepared. 10-100 μL of each sample were placed into a new glass tube followed by 
addition of 20 μL 10% Mg(NO3)2 in ethanol and were dried to ashes in a flame. 300 μL 
of 0.5 M HCl were added after tubes cooled down and samples were boiled a water bath 
for 15 min. Six parts of 0.42% (NH4)6 Mo7O24 in 1 M H2SO4 and one part of 10% 
C6H8O6 were mixed together before use. 700 μL of this mixture were added into the 
sample tubes and samples were incubated at 37ºC for 1 hr. Absorbance of each sample at 
820 nm was determined by spectrophotometer (SHIMADZU, UV-1601) and the final 
concentration of lipid was calculated from a plot of the absorbance at 820 nm as a 
function of phosphorus concentrations. 
II.14 Transmission electron microscopy (TEM). 
Reconstituted rHDL and purified MacB nanodiscs samples were adsorbed onto 
carbon-coated copper grids at RT for 2 min. Then the grids were washed with double 
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distilled water and stained with 2% phosphotungstic acid (PTA) (pH 7.1) (Wlodawer, 
Segrest et al. 1979). Electron micrograph images of empty nanodiscs and MacB 
nanodiscs were recorded with a JEOL 2000-FX transmission electron microscope (TEM) 
operated at 100 Kv. 
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Chapter 1: Characterization of the functionality of MacB variants. 
1.1 MacB variants exhibit different basal ATPase activity level.  
In order to characterize the mechanism of complex assembly of MacAB-TolC, we 
wanted to investigate the kinetic of MacAB-TolC assembly and the role of ATP in this 
process. For this purpose, we intended to develop a real time assay using surface plasmon 
resonance (SPR) approach to monitor the kinetic association between MacAB and TolC. 
The first critical step of SPR method is to immobilize target proteins onto the surface. In 
our study we decided to immobilize inner membrane transporter MacB onto the surface. 
The general transport mechanism of ABC-type transporters starts with the binding of ATP 
and substrates (Davidson, Dassa et al. 2008). To investigate the assembly of 
MacAB-TolC tripartite complex during transport process, MacB, as the substrates and 
ATP binding protein, is a good candidate for immobilization. In addition, immobilization 
of MacB onto the surface can provide us an opportunity to understand the kinetics of 
MacA-MacB bipartite complex assembly and the role of ATP in this process. 
In order to immobilize homogeneous and functional MacB onto the surface, we 
wanted to use streptavidin-coated SA chip. Streptavidin on the surface captures 
biotinylated proteins with high affinity and all the biotinylated proteins can be 
immobilized in a known and uniform orientation on the surface. In our expectation, the 
interaction between biotin and streptavidin could keep all immobilized MacB in an up 
and down orientation. Another advantage of using a SA chip is the neutral pH of the 
immobilization buffer. Both the amine and thiol coupling procedures require low pH (pH 
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4.8) during immobilization. Some proteins are unstable under such conditions and might 
aggregate or become inactive on the surface.  
For biotinylation purposes, we wanted to introduce a single cysteine substitution at 
either N- or C- terminal end of MacB, which could react with Maleimide-Polyethylene 
glycol (PEG2)-Biotin (MP-biotin). In the amino acid sequence of MacB, there are three 
intrinsic cysteine residues, at positions 56, 580 and 620 (Figure I.4). C580 and C620 are 
located in the hydrophobic TM region of MacB and are not accessible to N-ethyl 
maleimide (NEM) (Kobayashi, Nishino et al. 2003). C56, on the other hand, is located in 
the first putative loop region of MacB NBD and could react with MP-biotin. To avoid 
undesired biotinylation at position 56, we mutated this cysteine into alanine. We then 
introduced a D643C mutation into the C-terminal end of MacB
WT
 and MacB
C56A
, 
respectively (Figure I.4). D643 is located at the cytoplasmic end of MacB. 
Overexpression of MacB
D643C
 confers resistance to erythromycin upto MacB
WT
 level, 
indicating D643C is a functional silent substitution (Kobayashi, Nishino et al. 2003).  
Previous studies (Tikhonova, Devroy et al. 2007) suggest that both the cytoplasmic 
and periplasmic portions of MacB are important for the interaction with MacA and for the 
stimulation of MacB ATPase activity by MacA. We next constructed MacB variants with 
substitutions in both the cytoplasmic and periplasmic regions of MacB, which could 
disrupt different ATP hydrolysis steps MacB (Figure 1.1 A). D169, a highly conserved 
residue in the Walker B region of NBDs, is responsible for ATP hydrolysis by acting as a 
general base (Geourjon, Orelle et al. 2001). MacB
D169N
 completely loses its ATPase 
activity and fails to complement the hypersensitivity of E. coli W4680 (∆acrAB, ∆acrD) 
strain to macrolides (Tikhonova, Devroy et al. 2007). Thus, MacB
D169N
 was used as the 
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catalytical inactive MacB. To disrupt the interaction between MacA and MacB in the 
periplasmic regions, we deleted the large periplasmic loop (LPL) between TM1 and TM2 
of MacB to construct MacB
LPL
 mutant. This LPL region of MacB is proposed to be 
significant for the interaction between MacA-MacB and probably required for 
MacB-TolC interactions (Yum, Xu et al. 2009). For immobilization purposes, we 
introduced D643C point mutation into MacB
LPL
 and MacB
D169N
. The MacB
LPL
 and 
MacB
169
 discussed below are MacB
LPL
 and MacB
D169N
 with D643C substitution at the 
C-terminal end of MacB. Finally, to disrupt the binding of nucleotides, we mutated the 
highly conserved residue Y14 in the A-loop of MacB NBD. This Y14 stacks against the 
adenine ring of ATP and contributes to the nucleotide-binding affinity of NBDs in well 
characterized ABC transporters (Geourjon, Orelle et al. 2001; Carrier, Urbatsch et al. 
2007). We introduced cysteine at postion Y14 into MacB
C56A
 to construct MacB
YC
 
mutant. 
In order to determine how the sunstitutions in MacB affect the ATP hydrolysis of 
MacB, we measured the ATPase activities of these MacB variants in vitro. All MacB 
variants were purified under the same condition as described in Experimental Procedures 
II.5. The concentrations of MacB variants were measured by Bradford or DC assay. The 
quality of proteins was verified using SDS-PAGE followed by CBB staining (Figure 1.1 
B). The ATPase assay was carried out in HEPES buffer (pH 7.0) containing 20 mM 
HEPES-KOH, 5 mM DTT, 50 mM KCl at 37°C. 0.42 μM purified MacB variants and 1 
mM Mg-ATP were added into reactions. Measured specific ATPase activities are shown 
in Figure 1.1 C.  
MacB
D643C
 showed ATPase activity similar to that of MacB
WT
, indicating that 
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D643C substitution does not affect MacB function.  
MacB
C56A
 lost about 60% of MacB ATPase activity when compared to MacB
WT
, 
indicating that position C56 is detrimental to the MacB ATPase. C56 is located eight 
positions down-stream from the Walker A motif of MacB. This result demonstrates that 
C56 in the NBD domain of MacB might contribute to the ATP binding, hydrolysis or both 
activities.  
MacB
C56A/D643C
 showed comparable ATPase with MacB
C56A
, confirming that D643C 
has no effect on MacB function.  
On the other hand, the Y14C substitution further diminished the ATPase activity of 
MacB
C56A 
about three-fold. Since Y14 is involved in nucleotide binding to MacB, the loss 
of ATPase activity of MacB
YC
 could be due to the defect in ATP binding of MacB. It is 
also possible that Y14 may also contribute to the ATP hydrolysis of MacB. 
Moreover, in agreement with previous studies (Tikhonova, Devroy et al. 2007), 
MacB
D169N
 lost the ability to hydrolyze ATP, confirming that D169N substitution 
completely inactivates MacB.  
Surprisingly, MacB
LPL
 retained its ATPase activity, which was only about 40% 
lower than that of MacB
D
. The persistence of ATPase activity of MacB
LPL
 suggests that 
the large periplasmic loop of MacB does not play a significant role in MacB ATP 
hydrolysis. 
Previous studies suggest that the assembly of AcrAB-TolC tripartite complex is 
modulated by pH and the complexes are highly stable at pH 6.0 (Tikhonova, Dastidar et 
al. 2009; Tikhonova, Yamada et al. 2011). In order to capture the stable complexes of 
MacAB-TolC on the surface, we intended to use the MES buffer (pH 6.0) for our SPR 
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study. Since the ATPase assay above was carried out in HEPES buffer (pH 7.0), next we 
investigated whether MacB variants can hydrolyze ATP at pH 6.0 and how the ATPase 
activities of these MacB variants are affected by this pH change. For this purpose, we 
measured the ATPase activity of MacB variants in MES running buffer (pH 6.0) 
containing 20 mM MES-KOH (pH 6.0), 150 mM NaCl, 0.2% Triton X-100. All the 
measurements were carried out at 37°C with 0.42 μM MacB and 1 mM Mg-ATP in each 
reaction (Figure 1.1 D).  
Shift in pH from 7.0 to 6.0 decreased the ATPase activity of MacB
WT
 and MacB
D
 by 
about 50%. However, MacB
D
 still showed ATPase activity similar to that of MacB
WT 
at 
pH 6.0. This result confirms that MacB
D
 is functional as MacB
WT
 at pH 6.0.  
In agreement with the measured ATPase activity at pH 7.0, MacB
YC
 was defective 
in ATP hydrolysis at pH 6.0. The ATPase activity of MacB
YC
 was about four fold lower 
than that of MacB
WT
. 
Surprisingly, the specific ATPase activity of MacB
LPL
 at pH 6.0 is comparable to 
that of MacB
WT
, indicating that at pH 6.0 MacB
LPL
 can hydrolyze ATP with the same 
efficiency as MacB
WT
. 
These results suggest that MacB
D
 functions as MacB
WT
, whereas MacB
YC
 is 
defective in hydrolyzing ATP. In addition, MacB
LPL
 is functional more like MacB
WT
 at 
pH 6.0. 
Taken together, we are able to construct MacB variants with different ATP 
hydrolysis activities: MacB
D
, a functional ATPase, MacB
LPL
, a conditionally functional 
ATPase, MacB
YC
, an ineffective ATPase and MacB
169
, an inactive ATPase. 
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Figure 1.1 Specific ATPase activity of MacB
WT
 and its derivatives. A. Schematic 
representation of the secondary structures of MacB variants. The TMS, NBD, PCD 
domains of MacB and the walker A, signature sequence, walker B ranges of MacB NBD 
are indicated. Point substitutions are highlighted with black lines. B. 1 µg purified 
MacB
WT 
and MacB variants were separated by 12% SDS-PAGE and stained with CBB. 
C. Specific ATPase activity of MacB
WT
 and its derivatives measured in HEPES buffer 
(pH 7.0). Reactions contained 0.42 μM MacB and were carried out at 37°C in the 
presence of 1 mM Mg-ATP. Error bars are SDs (n = 3). D. Specific ATPase activity of 
MacB
WT
 and its derivatives measured in HEPES buffer (pH 7.0) and in MES buffer (pH 
6.0). The composition of reactions is the same as A and measurements were carried out at 
37°C.  
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1.2 Different conformational states of MacB variants.  
The above results show that MacB variants differ in their ATPase activities. One 
possible reason could be due to the conformational changes in MacB that affects the ATP 
binding and hydrolysis of MacB variants. To compare the conformational status of MacB 
variants, we used in vitro limited proteolysis. For this purpose, purified MacB variants 
were treated with increasing concentrations of trypsin in MES running buffer (pH 6.0) at 
37°C for 15 min and MacB digestion fragments were visualized by anti-MacB 
immunoblotting. As shown in Figure 1.2 A, at 10 µg/mL trypsin concentration, all three 
MacB variants were completely digested into 35, 34, 33 and 31 kD fragments. But the 
lower concentrations of trypsin revealed certain differences between proteins. The 
proteolytic patterns of MacB
D
 and MacB
169
 were identical with most of proteins digested 
into 35 kD fragment at 1μg/mL trypsin concentration. This result suggests that MacBD 
and MacB
169
 adopt the same conformation in detergent. However, MacB
YC
 showed a 
digestion profile different from that of MacB
D
 and MacB
169
. MacB
YC
 was more resistant 
to trypsin as seen from the presence of the whole length MacB
YC
 and its 60 and 50 kD 
fragments at 1 μg/mL trypsin. A 42 kD fragment was only detected in MacBYC 
proteolytic profile further suggesting that MacB
YC
 adopts a conformation different from 
that of MacB
D
 and MacB
169
. Whereas, in the case of MacB
LPL
, only two minor digested 
fragments of MacB
LPL
 were produced and none of them matched the fragments from the 
full length MacB variants. This is most likely because of the absence of trypsin digestion 
sites in MacB LPL.  
Since the ATPase activities of MacB variants were sensitive to pH, we also checked 
the proteolytic profiles of MacB variants in HEPES buffer (pH 7.0). Even though the 
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digestion patterns of MacB
D
, MacB
169
 and MacB
YC
 at pH 7.0 were similar to those at pH 
6.0, proteins were more resistant to trypsin as seen in the presence of the full length 
proteins and its 50 kD fragment at 1 μg/mL trypsin. In agreement with the digestion 
profiles at pH 6.0, no differences were detected between MacB
D
 and MacB
169
. However, 
MacB
YC
 digestion profile did not show the 38 kD fragment but extra fragments 33 and 31 
kD were present at 1 μg/mL trypsin, indicating that MacBYC is more sensitive to trypsin 
than MacB
D
 and MacB
169 
at pH 7.0. The 42 kD fragment was still unique to MacB
YC
. 
This result confirms that MacB
YC
 exhibits a different conformation from that of MacB
D
 
and MacB
169
. The conformational difference of MacB
YC
 could be one of the reasons for 
the loss of MacB
YC
 ATPase activity. In contrast, inactive MacB
169
 is caused by the 
disability of binding or hydrolyzing ATP rather than a structure defect. 
Comparison of the trypsin digestion profiles of MacB variants in Figure 1.2 revealed 
that MacB
YC
 showed opposite trend of resistance toward trypsin comparing with that of 
MacB
D
 and MacB
169
 at different pH. Interestingly, this trend was also seen in the ATPase 
activities of MacB
D
 and MacB
YC
 (Figure 1.2 D). MacB
YC
 exhibited higher ATPase 
activity at pH 6.0 than that at pH 7.0. However, the ATPase activities of MacB
D
 reduced 
about 50% from pH 7.0 to pH 6.0. These results suggest that MacB
YC
 is more stable at 
pH 6.0 but MacB
D
 is destabilized at pH 6.0.  
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Figure 1.2 Trypsin digestion patterns of MacB
D
, MacB
169
, MacB
YC
 and MacB
LPL
. A. 
0.42 μg of purified MacB variants were treated with increasing concentrations of trypsin 
(0.01, 0.1, 1.0, 10 μg/mL) in MES running buffer plus 8 mM MgCl2 (pH 6.0) and 
incubated at 37°C 15 min. Reactions were terminated by boiling in SDS-sample buffer 
for 5 min. MacB fragments were resolved on 12% SDS-PAGE and visualized by 
anti-MacB immunoblotting. The numbers on the right are the molecular weight (MW) of 
digestion products in kD calculated based on the mobility of fragments as compared to 
the standard protein marker. B. The same as A but reactions were carried out in HEPES 
running buffer (pH 7.0). 
 
1.3 ATP binding induces conformational changes of MacB variants.  
Previous studies show that MacB is more resistant to trypsin in the presence of 
nucleotides in vivo (Modali and Zgurskaya 2011). This finding is in agreement with the 
model that the binding of nucleotides to MacB triggers the closure of NBDs. To further 
explore the reasons for deactivation of MacB variants, we investigated the in vitro trypsin 
digestion patterns of MacB variants in the presence of nucleotides. 
For this purpose, purified MacB
 
variants were pre-mixed with 4 mM Mg-ATP, 4 mM 
Mg-ADP or 4 mM Mg-AMPPNP and incubated on ice for 5 min to allow the binding of 
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nucleotides before addition of increasing concentrations of trypsin. MacB
 
fragments were 
visualized by anti-MacB immunoblotting. At 1 μg/mL trypsin and pH 6.0 (Figure 1.3), 
the whole length proteins of MacB
D 
and MacB
169
 were detected in the presence not in the 
absence of nucleotides, suggesting that the binding of nucleotides notably protected these 
MacB variants from digestion. The protection against trypsin in the presence of 
nucleotides could also be seen for MacB
YC
 but with a significantly less level than that of 
MacB
D
 and MacB
169. At 1 μg/mL trypsin the proteolytic pattern of MacBYC in the 
absence of nucleotides was similar to that of MacB
D
 or MacB
169
 in the presence of 
nucleotides. This result suggests that the NBDs domains of MacB
YC
 are likely to be in a 
semi-open conformation which could lead to a reduced affinity towards nucleotides. 
Similarly, MacB
LPL
 was also more resistant to trypsin in the presence of nucleotides, 
meaning the closure of NBDs does not need the presence of periplasmic loop of MacB. 
Since ATP, ADP and AMP-PNP all resulted in the same protective changes of MacB 
variants against trypsin, we can conclude that the binding of nucleotides induce the same 
conformational changes in MacB variants. 
At 1 μg/mL trypsin and pH 7.0 (Figure 1.3), the disappearance of full length 
proteins and 60, 50, 38 kD fragments indicated that MacB
D
, MacB
YC
 and MacB
169
 were 
more susceptible to trypsin in the presence of nucleotides. The 42 kD fragment of 
MacB
YC
 in the nucleotide bound state can be clearly detected at 0.1 μg/mL trypsin. This 
result confirms that the MacB
YC
 has a conformation that is distinct from the nucleotide 
bound conformation of MacB
D
 and MacB
169
. Taken together, these results suggest that 
MacB
YC
 adopts a different conformational state from that of MacB
D
 and MacB
169
. 
Furthermore, the binding of nucleotides induces the closed conformation of MacB NBDs. 
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Figure 1.3 Trypsin digestion patterns of MacB
D
, MacB
169
, MacB
YC
 and MacB
LPL
 in 
the presence or absence of nucleotides. A. 0.42 μg of purified MacBD were pre-mixed 
with 4 mM Mg-ATP, 4 mM Mg-ADP and 4 mM Mg-AMPPNP when indicated. 
Reactions were incubated on ice for 5 min to allow the binding of nucleotides. 
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Proteolysis was carried out with indicated concentrations of trypsin in MES running 
buffer supplemented with 8 mM MgCl2 (pH 6.0) and HEPES running buffer (pH 7.0). 
Reactions were incubated at 37°C for 15 min. MacB
 
fragments were visualized by 
anti-MacB immunoblotting. B. The same as A but with 0.42 μg MacB169. C. The same as 
A but with 0.42 μg MacBYC. D. The same as A but with 0.42 μg MacBLPL in MES 
running buffer supplemented with 8 mM MgCl2 (pH 6.0). 
 
1.4 MacA stimulates the ATPase activity of MacB variants except for MacB
LPL
. 
Previous studies showed that MacA significantly stimulates MacB ATPase activity 
significantly when reconstituted together with MacB into proteoliposomes (Tikhonova, 
Devroy et al. 2007; Modali and Zgurskaya 2011). In order to investigate whether 
introducing mutations into MacB affect the MacA-dependent stimulation of MacB 
ATPase activity, we measured the ATPase activities of MacB variants in the presence or 
absence of MacA reconstituted into proteoliposomes. Purified MacB
WT
 and its 
derivatives were reconstituted into proteoliposomes alone or together with MacA. 0.42 
μM MacB in proteoliposomes and 1 mM Mg-ATP were added into each reaction and all 
measurements were carried out in HEPES buffer (pH 7.0) at 37°C (Figure 1.4). In 
agreement with previous studies (Tikhonova, Devroy et al. 2007), MacA stimulated by 25 
fold the ATPase activities of both MacB
D
 and MacB
WT
. Thus, in proteoliposomes MacB
D
 
functions as MacB
WT
. MacB
C56A
, MacB
C56A/D643C
 and MacB
YC
 alone in proteoliposomes 
still showed defect in hydrolyzing ATP comparing to that of MacB
WT
. However, MacA 
reconstituted together with MacB variants into proteoliposomes managed to rescue the 
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loss of ATPase activities of MacB variants but not to the same extent as that of MacB
WT
. 
This result suggests that introducing these substitutions in the NBDs of MacB cause 
minimal disruptions of the interaction between MacA and MacB. Interestingly, MacA 
failed to activate MacB
LPL
 in proteoliposomes with less than two fold increase in MacB 
ATPase, suggesting that the large periplasmic loop of MacB is involved in 
MacA-dependent stimulation of MacB ATPase. 
 
 
Figure 1.4 Specific ATPase activity of MacB and MacAB proteoliposomes. 
Proteoliposomes containing 0.42 μM MacB and 1 mM Mg-ATP were used in all reactions. 
Measurements were carried out at 37°C in HEPES buffer (pH 7.0). Error bars are SDs (n 
= 3). 
1.5 Kinetic properties of MacB variants.  
Even though the MacA-dependent stimulation of MacB ATPase is not as strong as in 
detergent, about 40% increase can be detected with 3:1 MacA to MacB molar ratio in 
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reaction (Tikhonova, Devroy et al. 2007). In order to investigate how the ATPase 
activities of MacB variants were stimulated by MacA in MES buffer (pH 6.0), we 
measured the ATP hydrolysis rate of MacB variants with different MacA to MacB ratio 
(Figure 1.5). All reactions contained 0.42 μM MacB and 1 mM Mg-ATP and were carried 
out in MES buffer (pH 6.0) at 20°C with different MacA to MacB ratio in each reaction. 
The ATP hydrolysis rate of MacB
WT
 and MacB
D
 increased about 30-40% at 3:1 MacA to 
MacB molar ratio and slightly decreased at higher MacA to MacB molar ratio. Even 
though the ATP hydrolysis rate of MacB
YC
 is four-fold lower than that of MacB
D
, the 
stimulation by MacA showed the same trend. This result implies that MacB
YC
 interacts 
with MacA the same way as MacBWT and MacBD. In agreement with the result in 
proteoliposomes, MacB
LPL
 had no response to the presence of MacA and no stimulation 
by MacA was detected, confirming that the periplasmic loop is important for 
MacA-dependent stimulation of MacB ATPase. 
To further characterize the kinetic properties of MacB and MacAB ATPase, we 
measured the ATP hydrolysis rate of MacB and MacAB variants in the presence of 
increasing concentrations of ATP. All reactions contained 0.42 μM MacB and MacA to 
MacB molar ratio was kept at 3:1. 0.1-6 mM Mg-ATP was added into reactions. To get 
kinetics parameters for MacB
WT
 and its derivatives, the MacB ATP hydrolysis rates were 
plotted as a function of ATP concentrations and data points were fit into 
Michaelis-Menten equation (Figure 1.6 & Table 1.1). Similar to MacB
WT
, MacB
D
 
hydrolyzed 4 ATP molecules per min, suggesting MacB
D
 has the same kinetic properties 
as MacB
WT
 in pH 6.0. MacB
YC
, on the other hand, could only hydrolyze less than one 
ATP per min. The Vmax value of MacB
YC
 decreased about 70%-80% compared to those of 
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MacB
WT
 and MacB
D
. These results indicate that MacB
YC
 is a slower ATPase than MacB
D
. 
The presence of MacA increased the Vmax values of MacB
WT
, MacB
D
 and MacB
YC
, 
suggesting that MacA is able to stimulate the ATPase activities of MacB variants. 
 KM represents the substrate concentration at which the reaction rate is half of Vmax 
and is considered to reflect the binding affinity of substrates towards enzymes. The KM 
values of MacB
D
 and MacB
YC
 were comparable but 40% lower than that of MacB
WT
, 
indicating that ATP has similar affinity towards MacB
D
 and MacB
YC
. This result is in 
conflict with our prediction that MacB
YC
 is defective in ATP binding. Since the ATP 
hydrolysis rates of MacB
YC
 measured in pH 6.0 at 20°C were considerably low, any 
experimental error could cause this deviation. On the other hand, the purified MacB
D
 
could be inactivated for some reasons leading to reducing in ATP binding affities. In the 
presence or absence of MacA the KM values of MacB
WT
 and MacB
D
 were similar, 
suggesting the presence of MacA does not significantly affect the MacB binding affinity 
toward ATP.  
The kcat/KM parameter evaluates the enzyme efficiency. As shown in Table 1.1, 
despite the difference in ATP hydrolysis stages, MacA elevates the ATP hydrolysis 
efficiencies of all MacB variants expect for MacB
LPL
. This result further suggests that the 
interaction between MacA and MacB variants remains the same.  
Taken together, MacB
D
 functions as MacB
WT
 and MacB
YC
 is a slower ATPase than 
MacB
D
 and MacB
WT
. Despite the differences in ATP hydrolysis abilities of MacB
D
, 
MacB
WT
 and MacB
YC
, MacA can stimulate the ATPase activities of all three MacB 
variants. MacB
LPL
 cannot be stimulated by MacA in both proteoliposomes and detergent, 
suggesting the LPL domain of MacB plays a significant role in MacA-dependent 
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stimulation of MacB ATPase. 
 
 
Figure 1.5 Dependence of MacB ATPase activity on MacA. All reactions contained 
0.7 μM MacB and 1 mM Mg-ATP and were carried out at 20°C in MES buffer (pH 6.0). 
Error bars are SDs (n = 3). 
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Figure 1.6 Dependence of ATP hydrolysis by MacB and MacAB in detergent 
micelles on the concentration of ATP. All reactions contained 0.42 μM MacB and were 
carried out at 20°C in MES buffer (pH 6.0). Data were fit into Michaelis-Menten 
equation. The MacA: MacB molar ratio was 3:1. Error bars are SDs (n = 3). 
 
Table 1.1 Kinetic parameters of MacB ATPase and its derivatives. 
Protein KM (mM) Vmax (μM/min) kcat (s
-1
) kcat/KM 
(M
-1
s
-1
) 
MacB
WT
 
MacAB
WT
 
MacB
D
 
MacAB
D
 
MacB
YC
 
MacAB
YC
 
1.74±0.1 
1.84±0.16 
2.41±0.15 
2.11±0.14 
2.5±0.32 
4.7±0.43 
1.82±0.05 
2.29±0.08 
1.88±0.05 
2.47±0.06 
0.25±0.014 
0.52±0.028 
0.072±0.001 
0.091±0.002 
0.074±0.002 
0.098±0.001 
0.01±0.0003 
0.021±0.0007 
41.5±0.57 
49.4±1.08 
30.9±1.24 
46.5±0.47 
3.97±0.12 
4.39±0.15 
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1.6 Mutations in MacB affect the macrolide drugs resistance of E. coli W4680AD 
(∆acrAB, ∆acrD) cells.  
MacAB-TolC efflux pumps use the energy generated from ATP hydrolysis to 
transport macrolides across the membrane. Thus, functional MacB is required in this 
process as the motor. Since MacB variants are in different ATP hydrolysis state, we next 
investigated whether MacB
WT
, MacB
169
, MacB
YC
 and MacB
LPL
 are functional in 
transport of macrolides. For this purpose, we measured the minimal inhibitory 
concentrations (MIC) of E. coli W4680AD (∆acrAB, ∆acrD) cells carrying plasmids that 
produce MacA and MacB variants (Table 1.2). The major MDR transporter acrAB gene 
in E. coli W4680AD (∆acrAB, ∆acrD) strain is deleted from the chromosome. As a result, 
this strain is highly susceptible to macrolides and other antibiotics. When overproduced 
in this strain, MacAB confers resistance to macrolide drugs erythromycin and 
oleandomycin (Kobayashi, Nishino et al. 2001; Tikhonova, Devroy et al. 2007). In 
agreement with previous studies, MacAB
WT
 was able to complement the macrolide 
susceptibility of E. coli W4680AD cells upto 32 µg/mL of erythromycin and 78 µg/mL 
of oleandomycin. Inactive MacB
169
 failed to complement the macrolide susceptibility. On 
the other hand, MacB
YC
 could provide some resistance to macrolides but with about 8 
folds decrease comparing to that of MacB
WT
. These results demonstrate that MacB
YC 
retains some activities and can still form complex with MacA-TolC for the transportation 
of macrolides. Furthermore, the ATP hydrolysis rate of MacB is directly related to the 
transport function of MacB. However, MacB
LPL
 failed to rescue the hypersusceptibility of 
E. coli W4680AD cells, suggesting that MacB
LPL
 cannot couple the ATP hydrolysis to 
the transportation of macrolides probably due to the lack of periplasmic loop of MacB. 
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These results further imply that the efficient transport of macrolides by MacAB-TolC 
complex not only requires the active MacB ATPase but also the proper assembly of 
MacAB-TolC complex. 
In summary, we constructed MacB variants in different functional states. MacB
D
 
hydrolyzes ATP and interacts with MacA as MacB
WT
. The ATPase activity of MacB
LPL
 is 
comparabe to MacB
D
, but MacA fails to stimulate MacB
LPL
 ATPase activity. Even though 
MacB
YC
 is defective in ATP hydrolysis and adopt a different confirmation, MacA can still 
stimulate MacB
YC
 activity to some degree. MacB
169
 is completely inactive but has the 
same conformation as MacB
D
.  
 
Table 1.2 Macrolide susceptibilities of E. coli W4680AD (∆acrAB, ∆acrD) cells 
carrying plasmids producing MacA along with MacB variants (MIC, µg/mL). 
 
Plasmid Oleandomycin Erythromycin 
pUC 18 
MacAB
WT
 
MacAB
LPL
 
MacAB
YC
 
MacAB
169
 
2.44-4.88 
78 
4.88 
9.75-19.5 
2.44-4.88 
1 
32 
1-2 
4 
1 
 
 
Chapter 2: Investigation of the protein-protein interactions between 
MacA and MacB. 
2.1 Immobilization of MacB and a binding assay development.  
There are many well-established in vitro and in vivo assays to investigate the 
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interactions between proteins (Date 2007). In this study, we used the surface plasmon 
resonance (SPR) approach. SPR is an optical technique for exploring protein-protein 
interactions in vitro. It works by measuring the refractive index near the surface of a 
sensor to which a protein of interest has been immobilized. The advantages of SPR over 
other biochemical and biophysical techniques include speed, direct monitoring of binding 
without the need for labeling ligands, direct determination of association and dissociation 
rates, and small amounts of sample needed. SPR can be used for the affinity analysis, the 
kinetic analysis, the concentration assay, the binding stoichiometry, the thermodynamic 
analysis, the study of interaction mechanisms, etc. SPR has been used for the study of the 
protein-protein interactions between MFP and TolC (Tikhonova, Dastidar et al. 2009) and 
the complex assembly of AcrAB-TolC (Tikhonova, Yamada et al. 2011). In this study, we 
decided to use SPR for the investigation of the mechanism of complex assembly of 
MacAB-TolC.  
Previously, we described the construction of several MacB variants, MacB
D
, 
MacB
169
, MacB
LPL
 and MacB
YC
. All MacB variants have a D643C substitution at the 
C-terminal end of MacB and MacB
YC
 has an Y14C point mutation at the N-terminal end 
of MacB. Previous studies showed that these two cysteines in MacB are accessible to 
thiol-reactive reagents (Kobayashi, Nishino et al. 2003). To test whether the intrinsic and 
introduced cysteines are accessible to thiol-reactive reagent MP-biotin, we treated 
MacB
WT
 and MacB variants with MP-biotin and determined the biotinylation of these 
MacB variants. The biotinylated proteins were separated by 12% SDS-PAGE, transferred 
onto a PVDF membrane, incubated with streptavidin alkaline phosphatase conjugate and 
finally visualized by NBT/BCIP (Figure 2.1). MacB
WT
 with all three intrinsic cysteines in 
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place was not labeled with MP-biotin. Therefore, none of the three cysteines in MacB are 
accessible to MP-biotin and are unlikely to interfere with the biotinylation and 
immobilization processes. MacB
D
, MacB
169
, MacB
YC
 and MacB
LPL
 with cysteine on 
either N-terminus or C-terminus all can be biotinylated and were ready for 
immobilization. 
To develop a binding assay, the fully functional MacB
D
 was biotinylated and 
immobilized onto a SA chip with two different surface densities 1987 Responses Unit 
(RU) (D
high
) and 794 RU (D
low
). A change in the response signal by 1,000 RU is 
equivalent to the change in a surface concentration of 1 ng protein/mm
2
 or approximately 
6-10 mg/mL in a bulk protein. Therefore, about 100 µM and 40 µM concentrations of 
MacB were immobilized onto the high and low density surfaces, respectively. 0.25 µM 
purified MacA
WT
 was injected over MacB
Dhigh
, MacB
Dlow
 and the control surfaces 
simultaneously in HEPES running buffer (pH 7.0) containing 20 mM HEPE-KOH, 150 
mM NaCl, 0.2% TX-100 and MES running buffer (pH 6.0) containing 20 mM 
MES-KOH, 150 mM NaCl, 0.2% TX-100. The binding responses of MacA
WT
 to MacB 
surfaces were normalized by substracting the binding responeses on the control surface. 
Even though the binding of MacA
WT
 towards MacB was detected under both conditions, 
the specific binding response was more than twice higher at pH 6.0 than that at pH 7.0 
(Figure 2.2 A). In addition, the binding responses of MacA
WT
 were higher on the high 
density MacB
D
 surface than those on the low density MacB
D
 surface, indicating that the 
interaction between MacA
WT
 and MacB is specific (Figure 2.2 B). To detect notable 
binding signals, we decided to use MES running buffer (pH 6.0) for further study. 
In order to investigate whether MacB
D
 in MES running buffer (pH 6.0) is able to 
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bind nucleotides, we injected 0.25-8 mM Mg-ATP over MacB
Dhigh
 and MacB
Dlow
 
surfaces. The binding signals of ATP to MacB
D
 increased with increasing concentrations 
of ATP (Figure 2.2 C). In addition, the binding of ATP is specific to MacB
D
 because the 
changes in binding response were proportional to the surface densities of MacB
D
 (Figure 
2.2 D). 
Since MgCl2 is required for the ATP hydrolysis, we analyzed the effect of MgCl2 to 
MacA
WT
 binding towards MacB
D
. MacA
WT
 was premixed with increasing concentrations 
of MgCl2 and injected over MacB
D
 surface (1377 RU) (Figure 2.2 E). With increasing 
concentrations of MgCl2, the binding of MacA
WT
 to MacB
D
 decreased about 40% and 
this negative effect remained the same after 8 mM MgCl2. In order to eliminate the effect 
of MgCl2 to MacA binding, we decided to use MES running buffer (pH 6.0) 
supplemented with 8mM MgCl2 for binding assay.  
In addition, the MacA-MacB complex remained stable under different mild 
regeneration conditions such as increased pH and salt concentrations or addition of 
zwitterionic detergents. Therefore after scanning various binding and regeneration buffer, 
we decided to use MES running buffer (pH 6.0) supplemented with 8 mM MgCl2 as 
running buffer. Biffer containing 500 mM MgCl2, 20 mM Tris-HCl (pH 8.0), 150 mM 
NaCl, 0.2% TX-100 were set as the regeneration buffer.  
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Figure 2.1 Biotinylation of MacB
WT
 and its derivatives. 0.5 μg of each MP-biotin 
treated protein was separated by 12 % SDS-PAGE, transferred onto a PVDF membrane 
and incubated with streptavidin alkaline phosphatase. Biotinylated MacB
D
, MacB
YC
, 
MacB
169
 and MacB
LPL
 were visualized by NBT/BCIP. 
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Figure 2.2 Development of a binding assay. A. Binding of 0.25 µM MacA
WT
 to MacB
D
 
(998 RU) surface in MES (pH 6.0) and HEPES (pH 7.0) running buffers. In all 
experiments, MacA
WT
 was injected at a constant rate of 50 mL min
-1
. The binding 
responses of MacA
WT
 to MacB surfaces were normalized by subtracting the binding 
responses on the control surface. B. Binding of 0.25 µM MacA
WT
 to MacB
Dlow
 (794 RU) 
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and MacB
Dhigh 
(1978 RU) surfaces. C. Sensorgrams of ATP binding to MacB
D
 surfaces. 
0.25-8 mM of ATP were injected over MacB
Dhigh
 (1978 RU) and MacB
Dlow 
(794 RU) 
surfaces in MES running buffer (pH 6.0). D. Equilibrium binding responses of ATP to 
MacB
Dlow
 (794 RU) and MacB
Dhigh 
(1978 RU) surfaces were plotted as a function of ATP 
concentrations. E. Binding of MacA to MacB in the presence of increasing concentrations 
of MgCl2. 0.5 µM MacA
WT
 were premixed with 0.25-16 mM MgCl2 and injected over 
MacB
D
 (1377 RU) surface. Sensorgrams were normalized by subtracting the binding 
responses of increasing concentrations of MgCl2 and running buffer as double reference. 
MacA
WT
 injected alone was indicated as a red line. 
 
2.2 Immobilized MacB variants bind nucleotides.  
MacB is suggested to function as a dimer (Tikhonova, Devroy et al. 2007; Lin, 
Bavro et al. 2009). To confirm that the purified MacB retains its structure in detergent, we 
analyzed purified MacB by size exclusion chromatography (SEC). We self-packed a 1 
mL Sephacryl
TM
 S-300 gel filtration column and equilibrated it with MES (pH 6.0) 
running buffer in the presence or absence of 8 mM MgCl2. 5-10 µg of purified MacB was 
pre-mixed with the size standard containing BSA (66 kD), alcohol dehydrogenase (150 
kD) and ferritin (440 kD) and loaded onto the column. Fractions were collected and 
analyzed using 12% SDS-PAGE followed by silver staining. Figure 2.3 shows the 
quantitated intensity of protein bonds plotted as a function of the fraction number. MacB, 
with 145 kD MW for a dimer, eluted as a single peak, which overlapped with the peak of 
alcohol dehydrogenase (AD, 150 kD). From the gel filtration results, we can conclude 
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that in MES running buffer (pH 6.0) purified MacB is a stable homogeneous dimer. 
For kinetic studies, we immobilized biotinylated MacB
D
, MacB
169
, MacB
YC
 and 
MacB
LPL
 onto the surfaces with 1377 RU, 1462 RU, 1340 RU and 800 RU surface 
densities, respectively. To determine whether immobilized MacB variants were capable 
of binding nucleotides and further compare their affinities towards nucleotides, two-fold 
dilutions of 0.25 to 8 mM Mg-ATP, Mg-ADP and Mg-AMP-PNP were injected over 
MacB surfaces and control surface in MES running buffer (pH 6.0) supplemented with 8 
mM MgCl2.  
The binding of ATP generated the largest responses, implying that ATP may have 
the highest binding affinity towards MacB
D
. At all nucleotide concentrations, the binding 
responses reached steady-state rapidly and nucleotides dissociated from MacB
D
 within 5s, 
indicating that the binding reaction is reversible (Figure 2.4 A). The binding curves of 
ATP and ADP to MacB
D
 surfaces were similar and the absolute binding responses 
(Figure 2.4 B) were also comparable between ATP and ADP. The binding responses of 
AMP-PNP were much lower than those of ATP and ADP at the same concentrations, 
which might be explained by the structure dissimilarity of AMP-PNP. We could not fit 
the nucleotide binding curves into any available kinetic models. The shapes of the curves 
suggest the presence of at least two binding steps, the high-affinity step in the range of 
0.5-2.0 mM nucleotides and the low affinity step in a high millimolar range. The KM 
value of MacB 1.7-2.5 mM (Table 1.1) is in the range of the high affinity step. The 
nucleotide binding signals increased non-monotonously at nucleotide concentrations 
more than 4 mM, which could come from the contribution of additional factors, such as 
chemical or conformational changes of MacB or low non-specific interactions. 
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Despite the inactivation of MacB
169
 ATPase, MacB
169
 was able to bind nucleotides 
with comparable affinity to that of MacB
D
, indicating that the inactivation of the catalytic 
site of MacB
169
 has no effect on nucleotides binding.  
On the other hand, the binding responses of ATP and ADP on MacB
YC
 surface were 
approximately two times less than those of MacB
D
 and MacB
169
. Furthermore, MacB
YC
 
did not bind AMP-PNP. These results suggest that MacB
YC
, adopting a different 
conformation, is defective in nucleotides binding. 
As described in Chapter 1.1, we find that at pH 6.0 MacB
LPL
 can hydrolyze ATP 
with the same efficiency as MacB
D
 at pH 6.0. In agreement, immobilized MacB
LPL
 has 
binding affinity towards nucleotides similar to that of MacB
D
, indicating that deletion of 
periplasmic loop does not affect the nucleotide binding by MacB.  
Taken together, MacB
169
 and MacB
LPL
 can bind nucleotides with the same affinity 
as MacB
WT
, whereas MacB
YC
 is defective in nucleotide binding.  
 
 
Figure 2.3 Gel filtration analysis of MacB
D
, MacA
S 
and MacA
WT
. Purified MacB
D
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(purple line), MacA
WT
 (solid and dash black line) and MacA
S
 (orange line) 5-10 μg each 
were pre-mixed with a similar amount of the size standard containing BSA (66 kD, red 
line), alcohol dehydrogenase (150 kD, green line) and ferritin (440 kD, blue line). The 
mixture were loaded onto a self-packed 1 mL Sephacryl
TM 
S-300 column equilibrated 
with MES running buffer (pH 6.0) in the presence or absence of 8 mM MgCl2. Fractions 
were collected and then analyzed using 12% SDS-PAGE followed by silver staining. The 
intensity of protein bands on SDS-PAGE was further analyzed by Image J and plotted as 
a function of the fraction number. 
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Figure 2.4 Immobilized MacB binds ATP, ADP and AMP-PNP. A. Sensorgrams of 
two-fold dilutions of 0.25-8 mM indicated nucleotides injected over MacB
D
 (1377 RU), 
MacB
169
 (1462RU), MacB
YC
 (1340 RU) and MacB
LPL
 (800 RU) surfaces in MES 
running buffer (pH 6.0) supplemented with 8 mM MgCl2 B. Equilibrium binding 
responses of nucleotides from sensorgrams of A were plotted as a function of nucleotide 
concentrations. Binding responses were normalized to differences in surface densities and 
molecular masses of MacB variants.  
  
2.3 MacAWT forms oligomer in solution.  
In general, affinity and kinetic measurement of protein interactions require that each 
analyte molecule stays in a monovalent and homogeneous manner. The heterogeneity of 
analytes makes kinetics studies ambiguous. Thus, it is essential to ensure the 
homogeneity of analytes which is mostly achieved from purifying the monomeric peak 
by size exclusion chromatography (SEC) immediately before SPR. MacA
S
 exists as a 
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monomer in solution but forms heterogeneous oligomers at high concentrations 
(Tikhonova, Dastidar et al. 2009; Yum, Xu et al. 2009). MacA
WT
 is suggested to exit as a 
hexamer (Xu, Sim et al. 2009; Yum, Xu et al. 2009). Before the kinetic study of MacA 
and MacB interactions, we wanted to determine the oligomeric state of MacA
S
 and 
MacA
WT
 in MES running buffer (pH 6.0).  
We self-packed a 1 mL Sephacryl
TM
 S-300 gel filtration column and equilibrated it 
with MES running buffer (pH 6.0) with or without 8 mM MgCl2. MacA
WT
 and MacA
S
 
were pre-mixed with a similar amount of the size standard containing BSA (66 kD), 
alcohol dehydrogenase (150 kD) and ferritin (440 kD) and loaded onto the column. 
MacA
WT
 was eluted as a single symmetric peak (Figure 2.3) with the apparent molecular 
weight higher than that of 440 kD ferritin. The size of MacA
WT
 was the same in MES 
running buffer (pH 6.0) in the presence or absence of 8 mM MgCl2. Therefore, MacA
WT
 
forms stable, homogenous oligomer and MgCl2 had no effect on the oligomeric state of 
MacA
WT
.  
MacA
S
 was eluted as a single peak between 66 kD BSA and 150 kD AD with an 
apparent MW about 80 kD. This result suggests that in MES running buffer (pH 6.0) 
MacA
S
 has a lower oligomeric level than that of MacA
WT
 which is most likely to be in a 
monomeric form. 
 
2.4 MacAWT binds MacB with nanomolar affinity.  
As described in Section II.2, we constructed MacB variants with defects in ATP 
binding, ATP hydrolysis and MacA-dependent stimulation. Our next question is how the 
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ability of binding or hydrolyzing ATP of MacB affects the binding kinetics between 
MacA-MacB. To characterize the kinetics of MacA-MacB association, two-fold dilutions 
of MacA
WT
 were injected over MacB variant surfaces in MES running buffer (pH 6.0) 
supplemented with 8 mM MgCl2  (Figure 2.5). MacA
WT
 generated a robust binding 
response on MacB
D
 surface even at low nanomolar concentrations of MacA
WT
 (Figure 
2.5 A).  
Quantitative analysis of the binding curves revealed that double-exponential rate 
equations could be used to approximate the association and dissociation phase of 
MacA
WT
, indicating multiple binding events. We tried to fit the binding curves of MacA 
to MacB into different kinetic models such as 1:1 binding model, sequential binding 
model, and two state model (TS). The best kinetic model for MacA
WT
-MacB
D
 binding 
curves was TS model that assumes that MacA
WT
 binds MacB
D
 first and this association 
induces further conformational changes in MacB. The on-rate of MacA-MacB
D
 
association was about 10
4
 M
-4
s
-1
 (Table 2.1). The 10
-2 
s
-1 
off-rate, representing the 
complex stability, exceeded the turnover number of MacB
D
 ATPase (Table 1.1) about ten 
folds, suggesting that the MacA-MacB complex remains stable during ATP hydrolysis 
process. The equilibrium dissociation constant was calculated from the kinetic parameters 
in Table 2.1 MacA
WT
 binds MacB with a high affinity around 10
-8
 M. 
Immobilized MacB
169
, MacB
YC
 and MacB
LPL
 bind MacA
WT
 with similar affinities 
and kinetics to that of MacB
D 
(Figure 2.5 B-D). Even though the normalized binding 
responses of MacA
WT
 differed among MacB variants, the kinetics of MacA
WT
-MacB 
association was quite similar with all rate constants and equilibrium dissociation 
constants varied within 30%. Therefore, neither the periplasmic loop, catalytic activity 
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nor the correct NBDs conformation of MacB is required for the binding of MacA
WT
 to 
MacB. All this results further suggest that the interactions between TM domains of MacA 
and MacB contribute significantly to the high affinity binding of MacA to MacB. 
 
 
Figure 2.5 MacA
WT
 binds MacB variants. Sensorgrams (red lines) of two-fold dilutions 
of 31.3-1000 nM MacA
WT
 injected over MacB
D
 (1377 RU) (A), MacB
169
 (1462 RU) (B), 
MacB
YC
 (1340 RU) (C) and MacB
LPL 
(800 RU) (D) surfaces in MES running buffer (pH 
6.0) supplemented with 8 mM MgCl2. Sensorgrams are fit globally into TS model (black 
lines). 
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Table 2.1 Kinetic parameters of MacA-MacB interactions in the presence of nucleotides 
Data were fit globally using the TS model. k-1, k-2, k1 and k2 are microscopic rate constants. Equilibrium dissociation constants (KD) 
were calculated from the ratio of the dissociation and association rate constants. 
 
2.5 
Surface ka1(M
-1·s-1) kd1 (s
-1) ka2  (s
-1) kd2 (s
-1) KD (M) Chi 
MacBD (2.97±0.08)×104 (2.95±2.40) ×10-2 (2.06±0.13)×10-2 (10.7±1.86)×10-4 5.18×10-8 53.9 
MacBD+ATP (4.17±0.12)×104 (3.56±0.26)×10-2 (1.89±0.11)×10-2 (3.55±3.55)×10-4 1.61×10-8 58.5 
MacBD+ADP (2.79±0.11)×104 (2.79±0.37)×10-2 (2.28±0.24)×10-2 (9.29±2.93)×10-4 4.07×10-8 44.3 
MacBD+AMPPNP (2.8±0.11)×104 (2.64±0.37)×10-2 (2.18±0.23)×10-2 (8.54±2.84)×10-4 3.6×10-8 68.4 
MacBYC (2.69±0.01)×104 (2.59±0.15)×10-2 (1.9±0.10)×10-2 (8.21±1.85)×10-4 4.17×10-8 52.4 
MacBYC+ATP (3.64±0.09)×104 (2.92±0.20)×10-2 (1.85±0.10)×10-2 (4.34±1.6)×10-4 1.88×10-8 62.4 
MacBYC+ADP (2.32±0.08)×104 (1.91±0.27)×10-2 (2.2±0.25)×10-2 (11.9±2.56)×10-4 4.46×10-8 37.5 
MacBYC+AMPPNP (2.54±0.10)×104 (2.43±0.37)×10-2 (2.32±0.27)×10-2 (9.36±3.08)×10-4 3.86×10-8 74.3 
MacBD169N (2.5±0.06)×104 (2.48±0.24)×10-2 (1.86±0.14)×10-2 (7.4±2.35)×10-4 3.94×10-8 35.3 
MacBD169N+ATP (3.56±0.10)×104 (2.84±0.24)×10-2 (1.9±0.13)×10-2 (4.25±2.07)×10-4 1.78×10-8 40.8 
MacBD169N+ADP (2.33±0.10)×104 (2.15±0.37)×10-2 (2.24±0.31)×10-2 (9.48±3.68)×10-4 3.89×10-8 26.3 
MacBD169N+AMPPNP (2.99±0.06)×104 (3.68±0.15)×10-2 (2.61±0.08)×10-2 (9.29±1.02)×10-4 4.37×10-8 46.8 
MacBLPL (3.96±0.05)×104 (2.27±0.12)×10-2 (1.82±0.17)×10-2 (15.3±3.93)×10-4 4.81×10-8 35.7 
MacBLPL+ATP (8.86±0.12)×104 (4.64±0.16)×10-2 (1.97±0.09)×10-2 (9.2±1.67)×10-4 2.44×10-8 26.9 
MacBLPL+ADP (5.17±0.01)×104 (2.90±0.004)×10-2 (3.31±0.15)×10-2 (26.3±2.50)×10-4 4.41×10-8 21.9 
MacBLPL+AMPPNP (5.07±0.09)×104 (4.79±0.06)×10-2 (2.27±0.05)×10-2 (11.5±0.21)×10-4 4.80×10-8 48.3 
7
3
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2.5 MacAS binds MacB but with lower affinity comparing with MacAWT.    
MacA
S
 has no TM domain and exists as a monomer in solution (Figure 2.3). To 
investigate how the removal of TM domain of MacA affects the interactions between 
MacA and MacB, increasing concentrations of MacA
S
 were injected over MacB surfaces 
in MES running buffer (pH 6.0) supplemented with 8 mM MgCl2. MacA
S
 bound all 
MacB variants (Figure 2.6). However, more than ten-fold more MacA
S
 were needed to 
reach the same binding responses as that of MacA
WT
, indicating that the TM domain of 
MacA contributes significantly to the binding affinity between MacA and MacB. The 
binding curves of MacA
S
-MacB were fit into various kinetic models, but experimental 
data showed a systematic deviation from all the models. Since MacA
S
 has no TM domain, 
it is possible that the binding of MacA
S
 and MacA
WT
 trigger different binding events 
towards MacB. In addition, the oligomerization of MacA
S
 on the surface and in the 
solution can also cause this deviation. 
Previous results showed that MacA
S
 cannot simulate the ATPase activity of MacB 
(Tikhonova, Devroy et al. 2007). The defect of MacA
S
 in binding to MacB can be one of 
the reasons for the lack of MacA-dependent stimulation of MacB ATPase. 
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Figure 2.6 MacA
S
 binds MacB variants. Sensorgrams (red lines) of two-fold dilutions 
of 500-8000 nM MacA
S
 injected over MacB
D
 (1377 RU) (A), MacB
169
 (1462 RU) (B) 
and MacB
YC
 (1340 RU) (C) surfaces in MES running buffer supplemented with 8 mM 
MgCl2 (pH 6.0). Sensorgrams of MacB
D
 surface were fit globally into TS model (black 
line) 
. 
2.6 ATP binding increases MacA-MacB affinity.  
To investigate how the binding and hydrolysis of ATP affect the kinetic association 
between MacA and MacB, 0.5 μM MacAWT was pre-mixed with two-fold dilutions of 
0.25-8 mM Mg-ATP, Mg-ADP or Mg-AMP-PNP in MES running buffer (pH 6.0) 
supplemented with 8 mM MgCl2 and injected over MacB
D
, MacB
169
, MacB
YC
 and 
MacB
LPL
 surfaces. To determine how nucleotides affect MacA binding to MacB, the 
responses from nucleotides alone were subtracted from the binding responses of MacA
WT
 
plus nucleotides. The normalized binding curves were fitted locally to obtain a kobs value, 
which represents both the on- and off- rates in binding reactions. The kobs values were 
then plotted as a function of nucleotide concentrations as shown in Figure 2.7. With 
increasing concentrations of ADP, the value of kobs decreased about 15% at 1 mM ADP 
and remained the same for up to 8 mM ADP. On the contrary, the kobs values increased 
when ATP was injected together with MacA
WT
. At 0.25 mM to 1 mM ATP concentration, 
the kobs values increased gradually about 30% and then slightly decreased with higher 
concentrations of ATP. No changes in kobs were observed in the presence of AMP-PNP, 
indicating that MacA-MacB interaction isn’t affected by AMP-PNP. Even though MacB 
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variants showed variable binding responses, the changes in kobs caused by different 
nucleotides remained the same.  
Since MacB variants differ in their abilities to hydrolyze ATP, the same changes in 
kobs suggest that the changes in MacA
WT
 binding are caused by ATP binding not ATP 
hydrolysis.  
To further characterize the kinetics of MacA-MacB association in the presence of 
nucleotides, increasing concentrations of MacA
WT
 were pre-mixed with constant 4 mM 
concentration of Mg-ATP, Mg-ADP and Mg-AMP-PNP and injected over MacB surfaces. 
Quantitative analysis of the binding curves revealed complex binding events that could be 
fit into by double-exponential rate equations. The best fitting model for MacA
WT
-MacB 
binding in the presence of nucleotides was also the TS model, which assumes a 
conformational change of MacB upon MacA-MacB association (Figure 2.8). However, 
some deviations from this model could be seen in curve alignments, indicating that the 
reaction could be more complex. The calculated equilibrium dissociation constants given 
in Table 2.1 yield the same high 10
-8
 M affinity for MacA
WT
 complex with all MacB 
variants in the presence of nucleotides. Interestingly, the binding affinity of 
MacA
WT
-MacB in the presence of 4 mM ATP was up to three fold higher than that in the 
absence nucleotides. This effect could be seen only in the presence of ATP but not in 
other nucleotides and all the MacA-MacB complexes were affected by ATP. We conclude 
that it is ATP binding not hydrolysis that enhances the affinity of MacA
WT
-MacB 
association. In Chapter 1.3, we suggested that the binding of nucleotides to MacB 
promotes the closed conformation of MacB NBD. Therefore taken together, this result 
further suggests that MacA
WT
 has a higher affinity to the ATP-bound state of MacB. 
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Figure 2.7 Dependence of kobs of MacA on the concentrations of nucleotides. 0.5 μM 
MacA
WT
 was pre-mixed with two-fold dilutions of 0.25-8 mM Mg-ATP (open symbols) 
or Mg-ADP (closed symbols) and injected over MacB
D
 (1377 RU, triangles), MacB
169
 
(1462 RU, circles), MacB
YC
 (1340 RU, squares) and MacB
LPL 
(800 RU, diamonds) 
surfaces in MES running buffer supplemented with 8 mM MgCl2 (pH 6.0). The 
sensorgrams were fit locally and the change in kobs values are plotted as a function of 
nucleotide concentrations. 
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Figure 2.8 MacA
WT
 binds MacB in the presence of nucleotides. A. Sensorgrams (red 
lines) of two-fold dilutions of 31.3-1000 nM MacA
WT
 pre-mixed with 4 mM indicated 
nucleotides and injected over MacB
D 
(1377 RU) surface in MES running buffer 
supplemented with 8 mM MgCl2 (pH 6.0). Sensorgrams were fit globally into TS model 
(black lines). B. The same as A but injected over MacB
169
 (1462 RU) surface. C. The 
same as B but injected over MacB
YC
 (1340 RU) surface. D. The same as B but injected 
over MacB
LPL 
(800 RU) surface.   
 
Chapter 3: Investigation of the protein-protein interactions between 
MacAB and TolC. 
3.1 Immobilized TolC binds MacAS and MacAWT.  
TolC, a versatile outer membrane channel, forms complex with MacAB to conduct 
the transportation of macrolides. Previous studies show that TolC can form complex with 
MacA
WT
 with a high nanomolar affinity (Tikhonova, Dastidar et al. 2009). However, 
whether MacB and TolC could directly interact with each other is unknown. The crystal 
structure of MacB PCD reveals some structural similarities to the periplasmic domain of 
RND-type transporter AcrB (Xu, Sim et al. 2009). The periplasmic portion of AcrB is 
70Å in length and can interact with TolC directly (Murakami, Nakashima et al. 2002; 
Tikhonova, Yamada et al. 2011). The PCD of MacB is much smaller than that of AcrB, so 
it may not be large enough to contact TolC in the periplasm cell membranes. In order to 
investigate the mechanism of complex assembly of MacAB-TolC, our first task was to 
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determine whether MacB can interact directly with TolC. For this purpose, we 
immobilized TolC
A269C
 onto biochip using thiol-coupling procedure. Since A269 is 
located in the extracellular loop at the top end of the β-strands of TolC, TolCA269C can be 
immobilized onto the surface with an upside down orientation. This arrangement makes 
the periplasmic coiled-coil domains of TolC available for the interactions with MacB and 
MacA.  
In order to confirm that TolC maintain its functionality after immobilization, 
increasing concentrations of MacA
S
 and MacA
WT
 in MES running buffer (pH 6.0) 
supplemented with 8 mM MgCl2 were injected over TolC
A269C
 surface. MacA
WT
 was able 
to bind TolC, indicating that the immobilized TolC retains its functionality and can be 
used for further analysis (Figure 3.1 B). On the other hand, MacA
S
 could bind TolC but 
higher concentrations were needed to detect this binding (Figure 3.1 A). One possible 
reason for the binding defect of MacA
S 
is that MacA
WT
 and MacA
S
 adopt different 
conformation in solution. In chapter 2.3, we conclude that MacA
WT
 and MacA
S
 stay in 
hexamer and monomer forms in solution respectively. In addition, in previous studies (Xu, 
Lee et al. 2011), the α-helical hairpin domains of MacA are suggested to be the docking 
site for the periplasmic coiled coil domain of TolC. Thus, another possible reason for the 
defect of MacA
S
 binding towards TolC is that the monomer form of MacA
S 
cannot 
provide enough docking sites for TolC binding.  
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Figure 3.1 Immobilized TolC binds MacA
S
 and MacA
WT
. A. Sensorgrams of two-fold 
dilutions of 1000-16000 nM MacA
S
 injected over TolC (790 RU) surface in MES running 
buffer supplemented with 8 mM MgCl2 (pH 6.0). B. Sensorgrams of two-fold dilutions of 
62.5-2000 nM MacA
WT
 injected over TolC (790 RU) surface in MES running buffer (pH 
6.0) supplemented with 8 mM MgCl2. 
 
 
3.2 TolC does not directly interact with MacB.  
To investigate the interaction between MacB and TolC, increasing concentrations of 
MacB
WT
 and MacB
LPL
 were injected over TolC surface in MES running buffer (pH 6.0) 
supplemented with 8 mM MgCl2. No binding responses were detected on TolC surface 
(Figure 3.2). Thus, both MacB
WT
 and MacB
LPL 
cannot interact with immobilized TolC. To 
confirm the results, in the reverse assay, increasing concentrations of TolC
WT
 were 
injected over MacB
D
 (RU 1600) and MacB
LPL
 (RU 800) surfaces. Since MacB
LPL
 mutant 
does not contain the periplamic loop domain, which is thought to be the site of TolC 
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interaction, no TolC binding is expected on MacB
LPL
 surface. However, some binding 
responses generated by increasing concentrations of TolC
WT
 can be detected on both 
MacB surfaces. These binding signals are most likely a result of non-specific interactions 
between α-helices of MacB and streptavidin or mismatch in buffer composition, rather 
than binding (Figure 3.3 A). We also investigated the binding of TolC
ΔLoop
 mutant to 
MacB surfaces. This TolC
ΔLoop
 has simultaneous alteration of the four residues of 
147GLVA150 to AGSG, which are located in the turn region between the outer helices H3 
and H4 of TolC. These mutations inactivated efflux activity without affecting 
cross-linkable interactions between TolC and AcrA or TolC and AcrB (Weeks, 
Celaya-Kolb et al. 2010). As in the case with TolC
WT
, the sensorgrams of TolC
ΔLoop
 
binding also suggest non-specific interactions between MacB and TolC (Figure 3.3 B). 
Taken together, these results suggest that MacB does not interact with TolC directly. 
 
 
Figure 3.2 Immobilized TolC cannot bind MacB. Sensorgrams of two-fold dilutions of 
62.5-1000 nM MacB
WT
 (A) or MacB
LPL
 (B) injected over TolC (790 RU) surface in MES 
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running buffer (pH 6.0) supplemented with 8 mM MgCl2. 
 
 
Figure 3.3 TolC
WT
 and TolC
ΔLoop
 cannot bind MacB. A. Sensorgrams of two-fold 
dilutions of 62.5-1000 nM TolC
WT 
injected over MacB
D
 (1600 RU) and MacB
LPL
 (800 
RU) surfaces as indicated in MES running buffer (pH 6.0) supplemented with 8 mM 
MgCl2. B. Sensorgrams of two-fold dilutions of 62.5-1000 nM TolC
ΔLoop 
injected over 
MacB
D
 (1600 RU) and MacB
LPL
 (800 RU) surfaces as indicated in MES running buffer 
(pH 6.0) supplemented with 8 mM MgCl2. 
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3.3 MacB is essential for the recruitment of TolC.  
In order to couple the energy generated by ATP hydrolysis to substrate transport 
across the outer membrane through TolC channel, MacAB is believed to go through 
conformational changes favorable for the recruitment of TolC and the formation of 
functional complexes. MacA is thought to play a significant role in this assembly process. 
Previous studies show that MacAB-TolC complexes can be detected and co-purified in 
vivo (Tikhonova, Devroy et al. 2007; Modali and Zgurskaya 2011). To investigate how 
the ATP hydrolysis state of MacB affects the recruitment of TolC by MacA, we purified 
MacA
WT
 expressed alone or together with MacB variants from E. coli W4680AD 
(ΔacrAB, ΔacrD) cells. The purified proteins were separated by 12% SDS-PAGE, 
transferred onto the PVDF membrane, incubated with anti-MacB, anti-MacA or anti-TolC 
rabbit polyclonal antibodies followed by alkaline- phosphatase-conjugated anti-rabbit 
IgG antibody and visualized by BCIP and NBT (Figure 3.4). Results showed that TolC 
can be co-purified with MacA
WT
 alone and MacA
WT
-MacB
WT
 but not with MacB alone, 
indicating that MacA
WT
 is required for the recruitment of TolC to form MacAB-TolC 
complexes. The amounts of co-purified TolC remained the same in MacA-MacB
169
 and 
MacA-MacB
YC
 samples, suggesting that the defect in MacB ATPase does not 
significantly affect the complex formation. Surprisingly, no TolC was co-purified with 
MacA-MacB
LPL
. In contrast, TolC is pulled down by MacA
WT
 alone but not in the 
complex with MacB
LPL
. These results demonstrate that the periplasmic loop of MacB is 
not only essential for the MacA-dependent stimulation of MacB ATPase but also for the 
proper assembly of MacAB-TolC complexes.  
To investigate the role of MacB LPL domain in the complex assembly of 
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MacAB-TolC, we pre-assembled MacA-MacB
WT
 and MacA-MacB
LPL
 complexes with 
different MacB to MacA stoichiometries and then injected the complexes over the TolC 
surface. Previously no MacB
WT
 or MacB
LPL
 binding were detected on TolC surface 
(Figure 3.1). If pre-assembled MacA-MacB complexes can be recruited onto TolC 
surface by MacA, the binding response of complexes should be higher than that of MacA 
alone, indicating that MacB is retained on TolC surface through MacA. On the contrary, 
a lower binding response for pre-assembled MacA-MacB complexes suggests that the 
presence of MacB interferes with MacA-TolC interaction. Figure 3.5 showed that the 
binding responses of MacA-MacB
WT
 complexes were increased compared to those of 
MacA
WT
 alone. On the other hand, MacB
LPL
 prevented MacA
WT
 from binding to TolC. 
This result supports the previous conclusion that the larger periplasmic loop of MacB is 
not only required for MacA-dependent stimulation of MacB ATPase activity of but is 
also involved in the assembly of MacAB-TolC complex.  
Taken together, these results further suggest that the MacA-dependent stimulation of 
MacB ATPase is coupled with TolC recruitment. 
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Figure 3.4 Co-purification of MacA and TolC with MacB
WT 
and its derivatives. 
6-his-tagged MacB
WT
 or its derivatives were purified from E. coli W4680AD (ΔacrAB, 
ΔacrD) cells carrying plasmids that co-express MacB variants along with MacAWT. The 
co-purification of MacA and TolC with MacB was analyzed by 12 % SDS-PAGE and 
immunoblotting with anti-MacB, anti-MacA and anti-TolC polyclonal antibodies. 
 
 
Figure 3.5 MacB
LPL
 fails to recruit TolC. 0.5 μM MacAWT alone (red line) and 0.5 μM 
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MacA
WT
 pre-mixed with 0.25 μM MacBWT (black line) or MacBLPL (blue line) were 
injected over TolC (790 RU) surface in MES running buffer (pH 6.0) supplemented with 
8 mM MgCl2. 
 
Chapter 4: Reconstitution of MacAB-TolC into nanodiscs.  
4.1 Construction and purification of tag-less ApoA-I.  
All three components of MacAB-TolC complex are membrane proteins and they are 
insoluble in aqueous buffer solutions. Therefore, to study the biological and physiological 
functions of these proteins, detergent and reconstituted proteoliposomes were used. In 
detergent, MacB can hydrolyze ATP, but the stimulation of MacB ATPase by MacA is not 
more than 50% (Tikhonova, Devroy et al. 2007). In detergents, MacB may exhibit a 
conformation different from that in the native environment. Furthermore, the interactions 
between MacA and MacB may be disrupted by detergent micelle. In contrary, MacA 
significantly stimulates the MacB ATPase when reconstituted together with MacB into 
proteoliposomes (Tikhonova, Devroy et al. 2007). However, the limitation of 
reconstituted proteoliposomes is that only on side of the protein is accessible to aqueous 
environment. Due to this character of proteoliposomes, we cannot investigate the 
nucleotide binding and complex assembly simultaneously. Thus, in order to create a 
membrane like environment for the study of functional tripartite complexes in vitro, we 
decided to reconstitute MacAB-TolC complexes into lipid nanodiscs. 
Nanodiscs are reconstituted high-density lipoprotein (rHDL), composed of a planar 
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bilayer of phospholipids surrounded by a dimer form of apolipoprotein A-I (apoA-I) 
(Figure 4.1 A). This reconstitution system has been elegantly adopted by laboratories to 
incorporate various membrane proteins into the phospholipid bilayer (Whorton, 
Jastrzebska et al. 2008) and functional studies based on this reconstituted system have 
been reported from numerous laboratories (Tsukamoto, Sinha et al. 2010). We expect that 
MacB reconstituted into nanodiscs will be accessible to nucleotides, substrates, MacA 
and TolC simultaneously. Therefore, this reconstituted system could help us to recreate a 
complete event for the macrolide transport through MacAB-TolC complex (Figure 4.1 
B). 
In order to establish a reconstitution system, we purified 6-His-tagged ApoA-I as 
described in (Ryan, Forte et al. 2003) and then optimized the reconstitution conditions 
using different phospholipids, detergents and protein compositions. Even though all 
tested recombination resulted in the formation of nanodiscs, to best mimic the lipid 
environment of E. coli, E. coli polar lipid extracts were used as the phospholipid source. 
Previous studies demonstrated that MacB is a functional ATPase in TX-100 (Tikhonova, 
Devroy et al. 2007). Thus, TX-100 was selected to solubilize lipid and MacB. In contrary, 
TolC was unstable in TX-100/lipid mixture and tended to aggregate. Thus, DDM was 
used instead of TX-100 for the reconstitution of TolC nanodiscs. The finalized 
reconstitution procedure was described in Experimental Procedures II.8.  
In order to further purify MacB and TolC nanodiscs using the 6 His-tag at the C 
terminal ends of MacB and TolC, respectively, we decided to remove the 6 his-tag from 
ApoA-I and fused an N-terminal intein-tag to apoA-I (Figure 4.1 C). The intein-tag can 
be self-cleaved from ApoA-I after DTT treatment, generating a tag less ApoA-I protein. 
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The ApoA-I gene fragment was cloned into a pTYB11 vector result in the fusion of the 
Intein-CDB tag to the N-terminal of ApoA-I (Figure 4.1 C). After several round 
optimizations of the expression and purification conditions, the expression temperature of 
intein-ApoA-I was set at 12°C. Before the separation of cytoplasmic fractions, cell lyste 
was treated with 0.5% TX-100 to release membrane associated intein-ApoA-I. The 
self-cleavage of Intein-tag from ApoA-I was carried out at RT for more than 16 hrs. A 
reasonable amount of tag-less ApoA-I protein with a MW around 27 kD can be purified 
as shown in Figure 4.1 D. This tag-less ApoA-I was used for the reconstitution of 
nanodiscs in the further studies. 
 
 
Figure 4.1 Reconstituion of nanodiscs. A. Diagram of a nanodisc with two copies of a 
membrane scaffold protein surrounding the hydrocarbon side chains of a lipid bilayer 
(Boldog, Grimme et al. 2006). B. Diagram of MacB nanodiscs with a substrate and ATP 
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accessible to both sides of MacB. C. The apoA-I gene was cloned into a pTYB11 vector 
and the arrangement of the insertion is indicated. D. 0.5 μg of purified ApoA-I protein 
was separated by 12 % SDS-PAGE and visualized by CBB staining. 
 
4.2 MacB and TolC can be reconstituted into nanodiscs.  
To investigate the protein-protein interactions of MacAB-TolC in vitro, we 
reconstituted both the inner membrane transporter MacB and the outer membrane 
channel TolC into nanodiscs. After reconstitution procedures, to purify protein associated 
nanodiscs, samples were loaded onto Ni
2+
-charged NTA column equilibrated buffer 
containing 20 mM Tris-HCl (pH 8.0), 100 mM NaCl. The MacB or TolC nanodiscs were 
eluted by buffer supplemented with 500 mM imidezole. The protein component in 
fractions was verified using 12% SDS-PAGE followed by silver staining (Figure 4.2 A). 
Non-MacB/TolC associated particles cannot be retained on the column as shown in the 
fractions of flow through and wash. The co-elution of MacB and TolC with ApoA-I could 
be detected in the fractions of 500 mM imidezole. Furthermore, the presense of lipids in 
these fractions were confirmed by measuring the lipid concnetrations. 
The 500 mM imidezole samples contained all MacB/TolC associated particles, 
which could be the mixtures of MacB/TolC containing nanodiscs and proteoliposomes. 
To further purify the protein containing nanodiscs, the samples were loaded onto 
YMC-Pack Diol-300 size exclusion column equilibrated in buffer containing 20 mM 
Tris-HCl (pH 8.0), 100 mM NaCl. The flow rate was set at 1 mL/min and the fractions 
were collected 0.5 min each. The presence of proteins was monitored by the absorbance 
 91 
 
at 280 nm. Nanodiscs were eluted later than proteoliposomes or other lipid containing 
vesicles due to the small sizes. Furthermore, to confirm the homogenicity of nanodiscs, 
the fractions corresponding to nanodiscs were reloaded onto a size exclusion column with 
a flow rate at 0.1 mL/min. The flow rate set here as considerably slow in oder to reveal 
the differences in sizes more precisely. Both empty and MacB nanodiscs eluted as single 
symmetric peaks with elution times of 72.14 min and 70.55 min, respectively, indicating 
that the reconstituted nanoidscs are homogeneous in sizes (Figure 4.2 B). The sizes of 
MacB nanodiscs were slightly larger than those of empty nanodiscs probably due to the 
insertion of MacB. 
To further verify the formation of nanodiscs, transmission eletron microscopy was 
utilized. The fractions collected from the peaks of empty and MacB nanodiscs were 
adsorbed onto carbon-coated copper grids at RT for 2 min. Then the grids were washed 
with double distilled water and stained with 2% phosphotungstic acid (PTA) (pH 7.1). 
The images of emty nanodiscs and MacB nanodiscs are shown (Figure 4.2 B). In 
agreement with previous studies (Chen, Ren et al. 2009), the nanodiscs are white and 
circular with diameters around 10 nm.  
Taken together, it is concluded that we have reconstituted empty nanodiscs and 
MacB/TolC containing nanodiscs. 
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Figure 4.2 MacB and TolC can be reconstituted into nanodiscs. A. Purification of 
MacB and TolC nanodiscs, respectively. Samples after reconstitution procedures were 
loaded onto Ni
2+
-charged NTA column equilibrated with buffer containing 20 mM 
Tris-HCl (pH 8.0), 100 mM NaCl. MacB or TolC nanodiscs were eluted by buffer 
supplemented with 500 mM Imidazole. B. Size exclusion chromatography (SEC) of 
nanodiscs. The flow rate was set at 0.1 mL/min. The presence of proteins was monitored 
by the absorbance at 280 nm and plotted as a function of the elution time. Insert: TEM 
images of nanodiscs or MacB nanodiscs. 
4.3 MacB reconstituted into nanodiscs can hydrolyze ATP.  
In Chapter 1.1, we demonstrate that purified MacB can hydrolyze ATP in detergent 
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TX-100 and in reconstituted proteoliposomes (Figure 1.1). In order to investigate the 
functionality of MacB in nanodiscs and how reconstitution of MacB into lipid bilayer 
affects the activity of MacB, we measured the specific ATPase activity of MacB in 
nanodiscs in the combination with TolC nanodiscs and MacA
S
. The reactions contained 
0.42 µM MacB in nanodiscs and 1 mM Mg-ATP and were carried out in HEPES buffer 
(pH 7.0) without 0.2% TX-100 at 37°C (Figure 4.3). MacB
WT
 in nanodiscs could 
hydrolyze ATP with a comparable activity to that of MacB
WT
 in detergent, suggesting that 
MacB
WT
 is functional in nanodiscs. TolC nanodiscs, empty nanodiscs, lipid itself and 
purified ApoA-I showed no activity towards ATP, indicating that only MacB contributes 
to the ATPase activity of MacB nanodiscs. Addition of TolC nanodiscs, MacA
S
 or the 
combination of these two into the reactions did not stimulate MacB ATPase. In agreement 
with previous studies (Tikhonova, Devroy et al. 2007), this result suggests that the 
presence of TMs of MacA is required for the MacA-dependent stimulation of MacB 
ATPase. Furthermore, TolC did not contribute to the ATPase activity of MacB. 
Surprisingly, MacB
C56A/D643C
, which lost 60% ATPase activity compared to MacB
WT
 in 
detergent (Figure 1.1), regained ATPase activity after reconstituted into nanodiscs. This 
result strongly suggests that reconstitution of MacB
C56A/D643C
 into lipid nanodiscs 
compensates the loss of MacB
C56A/D643C
 ATPase by providing a more native environment 
for MacB function. Therefore, this functional MacB
C56A/D643C
 in nanodiscs can be used 
for immobilization and kinetic study.  
For immobilization purposes, MacB
C56A/D643C
 was biotinylated and then 
reconstituted into nanodiscs. To investigate the effect of biotinylation to MacB ATPase, 
we measured the specific ATPase activity of biotinylated MacB
C56A/D643C
 in detergent and 
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in nanodiscs (Figure 4.2). Biotinylated MacB
C56A/D643C
 could hydrolyze ATP with a 
similar efficiency to that of unlabeled MacB
C56A/D643C
, indicating that biotinylation 
procedure does not affect the functionality of MacB. Furthermore, reconstitution of 
biotinylated MacB
C56A/D643C
 into nanodiscs rescued the loss of MacB ATPase to the level 
of MacB
WT
. 
Taken together, MacB
WT
 and MacB
C56A/D643C
 in nanodiscs are functional ATPases. 
This further suggests that reconstitution of MacB into nanodiscs provides us a more 
natural way to investigate the complex formation of MacAB-TolC. 
 
 
Figure 4.3 Specific ATPase activity of nanodiscs. Specific activity of MacB
WT
 and 
MacB
C56A/D643C
 in detergent or reconstitutied into nanodiscs in the precence of MacA
S
 
and TolC associated nanodiscs (MacB: TolC: MacA
S
 molar ratio 2:3:3). Reactions 
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contained 0.42 μM MacB in nanodiscs and were carried out in the presence of 1mM 
Mg-ATP at 37°C. Error bars are SDs (n = 3). 
 
4.4 Immobilized MacB nanodiscs bind ATP.  
In Chapter 2.2, we show that Immobilized MacB
WT
 and its derivatives are capable of 
binding ATP in MES (pH 6.0) running buffer. Therefore, we wanted to investigate 
whether MacB
C56A/D643C
 nanodiscs could bind ATP and how the binding of ATP to MacB 
was affected upon reconstitution. For this purpose, empty and MacB nanodiscs were 
immobilized onto a SA chip as described in Chapter 2.1 with and 2551 RU and 2783 RU 
surface densities, respectively. Increasing concentrations of ATP were injected over MacB 
nanodiscs surface, the empty nanodiscs surface and THE protein free surface 
simultaneously in MES running buffer (pH 6.0) and HEPES running buffer (pH 7.4) 
without TX-100. Binding responses were normalized by subtracting the responses from 
the protein free surface (Figure 4.4). The shape of ATP binding curves of MacB
C56A/D643C
 
in nanodiscs looked similar to those of MacB
D
 in detergent, implying that the binding 
kinetic of ATP to MacB is probably the same in detergent and in nanodiscs. The response 
curves reached steady-state rapidly and ATP dissociated from MacB surfaces within 5 sec, 
suggesting that the binding reaction is reversible. On the other hand, no binding 
responses were detected on empty nanodiscs surface, indicating that the binding of ATP is 
specific to MacB but not to phospholipids or ApoA-I proteins. In addition, the binding 
signals of ATP were more notable in MES running buffer (pH 6.0) compared to those in 
HEPES running buffer (pH 7.4). Therefore, MES running buffer (pH 6.0) will be used in 
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further studies.  
 
Figure 4.4 Immobilized MacB nanodiscs bind ATP. Sensorgrams of two-fold dilutions 
of 0.25-8 mM Mg-ATP injected over MacB
 
nanodiscs (2783 RU) surface and nanodiscs 
(2551 RU) surface in MES running buffer (pH 6.0) without TX-100 (A) or HEPES 
running buffer (pH 7.4) without TX-100 (B). 
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4.5 MacAS binds MacB nanodiscs.  
To investigate the interaction between MacA and MacB, increasing concentrations 
of MacA
S
 were injected over MacB nanodiscs surface and empty nanodiscs surface in 
MES running buffer (pH 6.0) without TX-100. MacA
S
 bound MacB nanodiscs (Figure 
4.5). However, the binding responses were also detected on nanodiscs surface but the 
signal was very low. At this point, it is difficult to conclude that MacA
S
 can interact with 
MacB in nanodiscs. More investigations need to be done in the future. 
 
 
Figure 4.5 Immobilized MacB nanodiscs bind MacA
S
. Sensorgrams of two-fold 
dilutions of 500-8000 nM MacA
S
 injected over MacB
 
nanodiscs (2783 RU) surface and 
nanodiscs (2551 RU) surface in MES running buffer (pH 6.0) without TX-100. 
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III. Discussion. 
One of the reasons why Gram-negative bacteria are more resistant to antibiotics than 
Gram-positive bacteria is the distinctive structural feature of their cell wall. It is 
composed of two membranes: the inner (IM) and the outer (OM) membrane. The outer 
membrane contributes to the intrinsic resistance by acting as an efficient permeability 
barrier (Nikaido 1998). The second key factor for the high level of resistance of 
Gram-negative bacteria towards antibiotics is the expression of multidrug efflux systems 
located in the cell envelope. Due to the double membrane arrangement, in Gram-negative 
bacteria the MDR efflux pumps form tripartite complexes for the direct translocation of 
diverse substrates from the cytoplasm or cytoplasmic membrane into the extracellular 
medium. These tripartite complexes are composed of an inner membrane transporter, a 
periplasmic membrane fusion (MFP) and an outer membrane channel. 
In E. coli, MacAB-TolC is the first experimentally described ATP-driven tripartite 
efflux pump which is involved in the extrusion of macrolides and enterotoxin (Kobayashi, 
Nishino et al. 2001; Yamanaka, Kobayashi et al. 2008). In this complex, MacA is a MFP, 
inserted into the inner membrane with one transmembrane (TM) segment. MacB is the 
inner membrane ABC-type transporter which uses ATP hydrolysis to energize the 
transport reaction. MacA and MacB together form the macrolide-specific efflux pump 
which required the third component, TolC, to efflux drugs out the cell. TolC is an outer 
membrane (OM) protein and is also an important component in other MDR efflux pumps. 
MacB functions as a dimer and purified MacB displays ATPase activity. MacA has a dual 
role: it acts as the physical linker between MacB and TolC and stimulates the ATPase 
activity of MacB (Tikhonova, Devroy et al. 2007). The molecular mechanism of such 
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stimulation remains unclear. It has been shown that MacA could function as a switch in 
coupling the energy consumption by transporter to the efflux of substrates (Modali and 
Zgurskaya 2011). TolC does not modulate the ATPase activities of MacB or MacAB 
complex. However, the function of MacAB depends on the association of TolC in vivo. 
How MacAB-TolC complex is assembled and whether or not ATP plays a significant role 
in this process remain unknown.  
In this study, we elucidated the mechanism of complex assembly of MacAB-TolC. 
The interaction between MacA and MacB is stimulated by ATP binding but remains 
unchanged during ATP hydrolysis cycle. We also found that the large periplasmic loop of 
MacB is required for MacA-dependent stimulation of MacB ATPase and contributes to 
recruitment of TolC into the tripartite complex. Furthermore, we successfully 
reconstituted MacB and TolC into lipid nanodiscs and intend to use them for the study of 
the biological and physiological functions of MacAB-TolC complex.  
III.1 The interaction between MacA and MacB is not sensitive to either ATP 
hydrolysis or conformational changes of MacB.  
In this study, we developed a real-time assay to monitor the protein interaction using 
the surface plasmon resonance approach. SPR is a more sensitive and quantitative 
technique for the investigation of protein-protein interactions comparing with the 
traditional approaches, such as isothermal calorimetry (ITC), immuno-precipitation et al. 
This technique has been used extensively in the past decade for studies of soluble 
proteins. Recently, scientists start to apply this method to the investigation of membrane 
proteins (de Keyzer, van der Does et al. 2003; Lewinson, Lee et al. 2010; Tikhonova, 
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Yamada et al. 2011).  
First, we investigated the kinetics of MacA and MacB interactions using the SPR 
approach. We find that MacA
WT
 forms a stable hexameric structure and binds functional 
active MacB
D
 with nanomolar affinity (Figure 2.3 & Table 2.1). In addition, the 
MacA
WT
-MacB complex remains stable during the entire ATP hydrolysis cycle. In 
previous studies (Tikhonova, Dastidar et al. 2009), a similar nanomolar affinity of 
MacA-TolC interaction was detected. These results suggest that the MacA can form 
stable complexes with MacB and TolC independently.  
In E. coli, AcrB together with AcrA and TolC functions as the major MDR pump. 
This tripartite complex translocates a wide variety of toxic compounds outside the cell 
using a proton gradient across the membrane (Zgurskaya and Nikaido 1999). 
MacAB-TolC only confers resistance to macrolides when overproduced in the cells 
lacking AcrAB-TolC (Kobayashi, Nishino et al. 2001). Recent studies on AcrAB-TolC 
tripartite complex revealed that the periplasmic MFP AcrA also assembles high affinity 
complexes with AcrB and TolC independently (Tikhonova, Dastidar et al. 2009; 
Tikhonova, Yamada et al. 2011). Since AcrAB-TolC and MacAB-TolC share the same 
outer membrane channel TolC and the stabilities of MFP-TolC complexes are similar, it is 
likely that the MFPs share a common role in the recruitment of TolC. However, the inner 
membrane transporter MacB and AcrB exhibit different structural and functional 
characters and they can have significantly distinctive effects on the recruitment of TolC 
upon binding to MFPs.  
Second, we investigated the involvement of ATP hydrolysis in MacA-MacB 
interactions. We constructed several MacB variants with substitutions affecting different 
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ATP hydrolysis stages. MacB
YC
 is defective in ATP hydrolysis and MacB
169
 is a 
completely inactive ATPase (Figure 1.1). Moreover, MacB
YC
 shows defect in binding 
nucleotides and exhibits a conformation different from that of MacB
D
 and MacB
169
 
(Figure 1.2). Surprisingly, despite the differences in the catalytic activity of MacB, 
MacA
WT
 binds MacB variants with similar nanomolar affinity (Table 2.1). We conclude 
that the interaction between MacA and MacB is not sensitive to either the ATP hydrolysis 
or the conformational changes of MacB. Our SPR results reveal that MacA
S
 binds 
MacB
D
 with a significantly lower affinity compared to MacA
WT 
(Figure 2.6). In addition, 
MacA
WT
 has similar affinities towards MacB
D
 and MacB
LPL
 lacking the large periplasmic 
loop (Figure 2.5). Therefore, in agreement with previous studies (Tikhonova, Devroy et al. 
2007), the TM segment of MacA plays a dominant role in the interaction between MacA 
and MacB. The interaction between the TMs of MacB and MacA make the major 
contribution to the MacA-MacB interaction captured on the surface. Since the amino acid 
residues Y14 and C56 are located in the NBDs of MacB, the conformational changes of 
MacB
YC
 could only occur in the NBDs leaving the alignment of MacB
YC
 TMs unchanged. 
Thus, MacA associates with MacB in the same manner and the same affinity as long as 
the TMs of MacA and MacB are in position. 
III.2 TolC cannot directly interact with MacB.  
The crystal structure of MacB periplasmic core domain (PCD) reveals some 
structural similarities to the periplamic domains of the RND-type multidrug efflux 
transporter AcrB (Yum, Xu et al. 2009). AcrB is a homotrimer and each monomer has 
two large periplasmic loops between TM1 and TM2, and TM7 and TM8 (Murakami, 
 102 
 
Nakashima et al. 2002). The periplasmic loops of AcrB from each protomer together form 
the porter domain and the TolC-docking domain, which function as a substrate binding 
pocket and a substrate exit domain, respectively. AcrB binds TolC directly and probably 
contributes to the opening of TolC channel (Zgurskaya, Krishnamoorthy et al. 2011).  
Even though MacB and AcrB share the same outer membrane channel TolC and 
there are structural similarities in the periplasmic domains of MacB and AcrB, our SPR 
result demonstrates that there is no interaction between MacB and TolC in vitro (Figure 
3.2 & 3.3). In addition, in agreement with previous in vivo studies (Modali and Zgurskaya 
2011), TolC cannot be co-purified by MacB alone (Figure 3.4). These results strongly 
suggest that TolC cannot directly interact with MacB.  
Previous studies showed conflicting results about MacB-TolC interaction (Lin, 
Bavro et al. 2009; Yum, Xu et al. 2009). Our studies suggest that TolC cannot interact 
directly with MacB. The structural study of MacB PCD revealed that the homotrimeric 
TolC is unlikely to bind the homodimeric MacB because of lack of a geometric fit 
between the two proteins (Yum, Xu et al. 2009). In addition, the extended length of MacB 
PCD protruding into the periplasm may not be long enough for the docking with the TolC 
tip. However, we cannot rule out a possibility that MacB can undergo conformational 
changes during the transport process and interact with TolC at some point suring transport 
process. 
III.3 The periplasmic loop of MacB is not required for MacA binding but is essential 
for MacA-mediated stimulation of MacB ATPase.  
If direct interaction between MacB and TolC is impossible, the MFP MacA must act 
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as the structural linker for the assembly of tripartite complexes and the functional 
transmitter for the translocation of substrates. MacA can interact with MacB on both sides 
of the membrane and within the membrane (Tikhonova, Devroy et al. 2007). The large 
periplasmic loop (LPL) of MacB is proposed to be the periplasmic site of interactions 
with MacA. To investigate the functional role of MacB LPL in MacA-MacB interaction, 
we deleted the LPL from MacB. We find that the LPL domain of MacB is not crucial for 
the interaction between MacA-MacB. However, the direct contact between the MP 
domain of MacA and the LPL domain of MacB is required for the MacA-dependent 
stimulation of MacB ATPase.  
ABC-type transporters can be classified into two categories based on the transport 
directions of substrates: i) importers, catalyzing the uptake of essential nutrients from the 
environment, ii) exporters, facilitating the extrusion of diverse compounds from the 
cytoplasm or lipid membrane. Even though these two types of ABC transporters exhibit 
different structural and functional characters, they are proposed to share a common 
transport mechanism. In this transport process, the nucleotide-dependent conformational 
transitions in NBDs drive the conformational changes in the TMDs (Rees, Johnson et al. 
2009). Since the LPL is connected to the TM1 and TM2 of MacB, the conformational 
changes in TMs can also trigger the changes in MacB LPL domain. These sequential 
changes in MacB conformation can alter the MacB interaction with MacA and lead to the 
MacA-dependent stimulation of MacB ATPase. However, MacB lacking the LPL cannot 
integrate these events into ATP hydrolysis, which causes the deficiency in the 
MacA-stimulation. Moreover, unlike most of the ABC transporters which normally 
consist of six TM segments, a C-terminal NBD and a very small periplasmic region 
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(Davidson, Dassa et al. 2008), MacB has four TM segments, an N-terminal NBD and a 
large periplasmic loop. This unique LPL domain of MacB may have some distinctive 
effects on MacB function and the complex assembly of MacAB-TolC, which need to be 
explored in the future. 
III.4 The binding of ATP increases the affinity of MacA-MacB complex.  
The ATP hydrolysis and substrate transport of MacB are significantly affected by 
MFP MacA (Lin, Bavro et al. 2009; Modali and Zgurskaya 2011). Previous studies 
suggested that MacA and ATP act synergistically on MacB and induce the closed 
conformation of MacB NBDs (Modali and Zgurskaya 2011). Figure 2.4 and 2.5 
demonstrate that MacA and nucleotides bind MacB independently. Our SPR results 
further reveal that the binding affinities of MacA to all MacB variants in the presence of 
nucleotides are in the nanomolar range. However, a three-fold increase in MacA-MacB 
binding affinity is observed only in the presence of ATP and all the MacA and MacB 
complexes are affected by ATP. Thus, we conclude that it is ATP binding not ATP 
hydrolysis that enhances the affinity of MacA towards MacB. The best kinetic models for 
MacA
WT
-MacB interaction in the presence or absence of ATP are all two-state models 
that MacA
WT
 binds MacB
D
 first and this association induces further conformational 
changes in MacB. Even though we cannot fit the binding of ATP into any model because 
of the fast on- and off-rate, it is likely that the association rate of ATP to MacB is faster 
than that of MacA to MacB. Therefore, ATP binds MacB and causes the dimerization of 
MacB. Sequentially, MacA form complex with the ATP-bound state of MacB with a 
higher affinity. Ultimately, the binding of MacA to MacB induces the closed 
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conformation of MacB NBDs.  
However, some deviations from TS model can be seen in curve fittings (Figure 2.5), 
indicating that the reaction could be more complex.  
The structures of several ABC-type exporters reveal a common coupling mechanism. 
Upon binding of nucleotides, TMs of exporters undergo a twisting motion for the 
transition from the inward-facing conformation to the outward-facing conformation. 
Furthermore, the canonical NBDs in the closed dimer requires a sliding motion along 
NBD interfaces (Dawson, Hollenstein et al. 2007; Oldham, Davidson et al. 2008). On the 
other hand, previous studies demonstrated that during the assembly of the transport 
complex the association with MacB induced conformational changes in MacA (Modali 
and Zgurskaya 2011). Therefore, the deviation of binding curves from the standard TS 
mode can be the combined actions of MacA and MacB. In addition, MacB is a 
structurally unique ABC-type transporter and MacA is the first MFP that is found to 
stimulate an ABC-type drug efflux transporte. The interaction between MacB and MacA 
in the presence of ATP could represent a unique mechanism, different from other 
transport systems. Furthermore, the binding curves of MacA to MacB
LPL
 show more 
systematic deviation from the TS model, suggesting that MacB lacking the LPL domain 
may go through a different conformation transition in the presence of ATP and MacA.  
Taken together, MacA has a higher affinity to MacB-ATP bound state. In detergent 
MacA and nucleotides only show modest effects towards MacB. However, the MacB 
ATPase was stimulated significantly by MacA in reconstituted proteoliposomes. It is 
possible that the effect of nucleotides on MacA-MacB interactions may be amplified 
tremendously in a lipid environment.  
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III.5 The mechanism of complex assembly of MacAB.  
Membrane fusion protein-dependent transporters are broadly represented in both 
Gram-negative and Gram-positive bacteria. These transporters exhibit different structures 
and biochemical mechanisms (Zgurskaya, Yamada et al. 2009). However, despite the 
mechanistic diversity of these transporters, all MFPs are thought to stimulate the activity 
of transporters for the transportation of substrates (Eswaran, Koronakis et al. 2004; Touze, 
Eswaran et al. 2004; Mikolosko, Bobyk et al. 2006) . The molecular mechanism of such 
stimulation remains unknown.  
Previous studies indicate that MP domain of MacA is required for the MacA 
facilitation of MacB function (Modali and Zgurskaya 2011) through the interaction with 
MacB LPL region. Our results suggest that the interaction between the MacB LPL 
domain and MacA is needed for the productive recruitment of TolC by MacA (Figure 
III.18&19). This result further imply that the MacA-dependent stimulation of MacB 
ATPase is coupled to the recruitment of TolC by MacA through the interactions between 
MacA and the large periplasmic loop of MacB. 
In summary we propose a mechanism of MacAB-TolC (Figure III.1). In the 
mechanism, MacB adopts a catalytic cycle similar to other ABC transporters with at least 
four steps: i) binding of ATP and substrate, ii) transport of substrate, iii) hydrolysis of 
ATP, and iv) release of ADP and Pi. Binding of ATP to MacB causes the dimerization of 
NBDs. MacA binds ATP-bound state of MacB with a higher affinity and promotes the 
closed conformation of MacB NBDs for ATP hydrolysis. Subsequently, the binding of 
TolC to MacA changes the conformation of the MP domain of MacA (Modali and 
Zgurskaya 2011). The MP domain of MacA then interacts with the LPL domain of MacB 
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and stimulated the MacB ATPase.  
 
 
Figure III. 1 A proposed transport mechanism of MacAB–TolC. 
 
III.6 Reconstitution of membrane proteins into lipid nanodiscs can be used to study 
MacAB-TolC system.  
All living organisms share one common feature that the cells are surrounded by at 
least one bilayer of membranes composed of phospholipids and proteins. Proteins 
inserted in the membrane bilayers are called membrane proteins. A major challenge for 
the study of membrane proteins is to obtain functionally active, water-soluble and 
monodisperse form of proteins (Borch and Hamann 2009). Historically, membrane 
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proteins have to be solubilized by detergents. But this treatment of proteins often tends to 
affect the activity of proteins and destabilizes the proteins and their interactions (Popot, 
Berry et al. 2003). In addition, some membrane protein systems need to associate with 
phospholipids to maintain their activities. Therefore, protein reconstituted into liposomes 
are used for biochemical studies of membrane proteins. However, liposomes are large, 
heterogeneous and can be prone to aggregation upon storage. Furthermore, liposomes are 
sensitive to changes in osmotic pressure.  
To overcome the difficulties in handling and studying membrane proteins, a method 
that can maintain membrane proteins monomerically in a native-like bilayer and 
simultaneously in solution is needed (Nath, Atkins et al. 2007). Nanodisc technology 
offers a solution to some of these challenges. Nanodiscs are soluble nanoscale 
phospholipid bilayers which can integrate membrane proteins into membrane bilayer by 
self-assembly (Bayburt, Grinkova et al. 2006). Nanodiscs are homogeneous, stable, and 
accessible to both sides of the phospholipid bilayer. These features of nanodiscs offer 
advantages over liposomes and detergent micelles (Bayburt and Sligar 2010). So far a 
number of membrane proteins were incorporated into nanodiscs for biochemical studies 
(Whorton, Bokoch et al. 2007; Lewinson, Lee et al. 2010). In the previous studies, MacB 
showed basal ATPase activity in TX-100 and this activity is either diminished by DDM 
or inhibited upon reconstitution into proteoliposomes (Tikhonova, Devroy et al. 2007). In 
order to fully understand the functionality of MacB and the mechanism of the complex 
assembly of MacAB-TolC in native environment, we reconstituted MacAB-TolC into 
lipid nanodiscs. This approach could overcome the negative effects of detergent micelles 
and liposomes and allow studying the complex in native environment. 
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MacB
WT
 in nanodiscs display basal ATPase activity as in TX-100. The inhibitory 
effect of lipid towards MacB ATPase in proteoliposomes does not exist in lipid nanodiscs, 
indicating that nanodiscs provide a more native environment for MacB functions. 
Intriguingly, MacB
C56A/D643C
, which lost at least 40% activity in TX-100, showed 
comparable ATPase with MacB
WT
 upon reconstituted into nanodiscs. This result is the 
most persuasive evidence to support the idea that MacB behaves more natively when 
reconstituted into nanodiscs. This MacB
C56A/D643C
 associated nanodiscs were able to bind 
ATP (Figure III.23), further suggesting that MacB in nanodiscs is functional. Even 
though more experiments need to be done to gain a complete insight about how this 
reconstituted system works, we believe that this system can be used to study 
MacAB-TolC complex.  
One of the potential problems with this reconstituted system is that we could only 
use MacA
S
 as the linker protein for the complex assembly which cannot stimulate the 
MacB ATPase. In the proposed transport mechanism of MacAB-TolC complex (Figure 
IV.1), MacA facilitates the closure of MacB NBDs in ATP-bound state and stimulates 
MacB ATPase upon TolC recruitment. All these functions of MacA require the presence 
of TMS domain, which is absent in MacA
S
. Therefore, MacA
S
 in this reconstituted 
system could be one of the major drawbacks. Thus, reconstitution of MacAB together 
into lipid nanodiscs can possibly provide more information about the MacA-dependent 
stimulation of MacB ATPase and the MacA-mediated complex assembly. This will be 
our next task to achieve in the future.  
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Appendix A. List of strains and plasmids 
  Relevant genotype or description Source or reference 
DH5α supE44 DlacU169 hsdR17 recA1 endA1 gyrA96 thi-1 relA1  
BL21(DE3)  F
–
ompT hsdSB(rB
–
 mB
–
)gal dcm Novagen 
ET103  BW25113 but ompT::kan (Tikhonova, Devroy et al. 2007) 
ECM2112  O. Lomovskaya  
 
MC4100 but ΔacrAB::k an tolC::Tn10 O. Lomovskaya 
W4680AD  K-12 but ∆acrAB ∆acrD (Tikhonova, Devroy et al. 2007) 
Plasmids   
pBAD/MycHis-C  Cloning vector, Amp
r 
 Invitrogen 
pBA
His
 pBAD/MycHis-C carrying macA-6His, Amp
r
 (Tikhonova, Devroy et al. 2007) 
pBBHis pBAD/MycHis-C carrying macB-6His, Amp
r
 (Tikhonova, Devroy et al. 2007) 
pBBD169N
His
 pBB
His
 expressing MacB-6His with D169N, Amp
r
 (Tikhonova, Devroy et al. 2007) 
pBBC56A
His
 pBB
His
 expressing MacB-6His with C56A, Amp
r
 (Tikhonova, Devroy et al. 2007) 
pBBY14C/C56A
His
 pBB
His
 expressing MacB-6His with Y14C/C56A, Amp
r
 (Tikhonova, Devroy et al. 2007) 
pBBC56A/D643C
His
 pBB
His
 expressing MacB-6His with C56A/D643C, Amp
r
 (Tikhonova, Devroy et al. 2007) 
pBBD643C
His
 pBB
His
 expressing MacB-6His with D643C, Amp
r
 This study 
pBBLPL
His
 pBB
His
 expressing MacB-6His lacking periplasmic loop , 
Amp
r
 
This study 
pBAB
His
 pBAD/MycHis-C carrying macAB-6His, Amp
r
 (Tikhonova, Devroy et al. 2007) 
1
1
5
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pBABD643C
His
 pBAB
His
 expressing MacB-6His with D643C, Amp
r
 This study 
pBABD169N
His
 pBAB
His
 expressing MacB-6His with D169N, Amp
r
 This study 
pBABY14C/C56A
Hi
s
 
pBAB
His
 expressing MacB-6His with Y14C/C56A, Amp
r
 This study 
pBABLPL
His
 pBAB
His
 expressing MacB-6His lacking the periplasmic 
loop , Amp
r
 
This study 
pUC18 Cloning vector, Amp
r
  
pUMacAB  pUC18 carrying macAB, Amp
r
 (Tikhonova, Devroy et al. 2007) 
pUMacABD643C pUMacAB expressing MacB D643C mutant , Amp
r
 This study 
pUMacABY14C/C5
6A 
pUMacAB expressing MacB Y14C/C56A mutant , Amp
r
 This study 
pUMacABD169N pUMacAB expressing MacB D169N mutant , Amp
r
 This study 
pUMacABLPL pUMacAB expressing MacB lacking the periplasmic loop , 
Amp
r
 
This study 
pTolC
His
  pTrc99A carrying tolC-6His, Amp
r
 (Tikhonova and Zgurskaya 
2004) 
pUA∆NHis pUZ11 expressing MacA∆N-6His fusion protein (Tikhonova, Devroy et al. 2007) 
pTYB11 Cloning vector, Amp
r
 NEW ENGLAND Biolabs 
pTYB-ApoA-I pTYB11 carrying Intein-apoA-I, Amp
r
 This study 
pNFXex pET20b
+
 carrying apoA-I, Amp
r
 (Ryan, Forte et al. 2003) 
 
 
1
1
6
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Appendix B. List of primers 
 Primer name Primer sequence (5’ TO 3’) reference 
apoA-I F GGTGGTACTAGTGATCCGCCGCAGAG Forward primer for amplifying apoA-I gene from 
pNFXex plasmid, with SpeI site 
apoA-I R GGTGGTGCGGCCGCCTCACTGGGTGTTAAGCTTC
TTCTTAG 
Reverse primer for amplifying apoA-I gene from 
pNFXex plasmid, with NotI site 
MacBD643C F ACGACTGGATCCAGTATGTGCTCTGGCACGAGAG 
CTCTCGTGCCAGAGCACATACTGGATCCAGTCGT 
Forward primer for introducing D643C mutation 
into macB in pBBHis plasmid 
MacBD643C R CTCTCGTGCCAGAGCACATACTGTGGATCCAGTC
GT 
Reverse primer for introducing D643C mutation 
into macB in pBBHis plasmid 
pBAD promter  CCTACCTGACGCTTTTTATCGC Forward primer for amplifying macB gene in 
pBB
His
 palsmid 
MacB LPL up GCCAAACAAATGGTGGCGACACGTACTTTACAAC
TG 
Reverse primer for amplifying 1-301 aa of macB 
in pBBD643C
His
 plasmid 
MacB LPL down CAGTTGTAAAGTACGTGTCGCCAGCACCATTTGT
TTGGC 
Forward primer for amplifying 518-648 aa of 
macB in pBBD643C
His
 plasmid  
MacAB F GCTAGGGTACCTACATGGGGTCGATTTC Forward primer for amplifying macAB gene in 
pUCMacAB plasmid, with NcoI site 
 
1
1
7
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MacAB R GCTAGCTGCACCTCATTGTGTACATCC Reverse primer for amplifying macAB gene in 
pUCMacAB plasmid, with PstI site 
MacBY14C F GATATTCGTCGCAGCTGTCCTGCCGGTGATG Forward primer for introducing Y14C mutation 
into macB in pBABHis plasmid 
MacBY14C R CATCACCGGCAGGACAGCTGCGACGAATATC Forward primer for introducing Y14C mutation 
into macB in pBABHis plasmid 
 
1
1
8
 
